Clinical Trials: Leukemia

Birmingham : University of Alabama Comprehensive Cancer Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Birmingham : University of Alabama at Birmingham

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Birmingham : University of Alabama at Birmingham

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Birmingham : Uab Comprehensive Cancer Center

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Birmingham : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

View More »

Birmingham : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Huntsville : Clearview Cancer Institute

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Huntsville : Clearview Cancer Institute

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Huntsville : Clearview Cancer Institute

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Huntsville : Clearview Cancer Institute

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Muscle Shoals : Northwest Alabama Cancer Center, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Muscle Shoals : Northwest Alabama Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Phoenix : Phoenix Children'S Hospital

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Phoenix :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Phoenix : Phoenix Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Scottsdale : Mayo Clinic

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

View More »

Scottsdale : Site Reference ID/Investigator# 59324 Updated

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Scottsdale : Virginia G. Piper Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Sedona : Arizona Oncology Associates, PC - NAHOA

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Tucson : University of Arizona (SPORE)

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Tucson : Arizona Cancer Center, University of Arizona

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Fayetteville : Highlands Oncology Group

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Hot Springs National Park : Genesis Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Jonesboro : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Jonesboro : NEA Baptist Clinic

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Little Rock : Hematology Oncology Services of Arkansas

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

View More »

Little Rock : Little Rock Hematology Oncology Associates

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Duarte : City of Hope

A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy

Duarte : City of Hope Updated

Allogeneic Stem Cell Transplantation with a Novel Conditioning Therapy Helical Tomotherapy, Melphalan, and Fludarabine in Hematological Malignancies

Duarte : City of Hope Updated

An Open Label Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of the MEK Inhibitor GSK1120212 in Subjects with Relapsed or Refractory Leukemias.

Duarte : City of Hope Updated

CALGB 10403: An Intergroup Phase II Clinical Trial for Adolescents and Young Adults with Untreated Acute Lymphoblastic Leukemia (ALL)

Duarte : City of Hope Updated

COG #AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

Duarte : City of Hope Updated

COG AALL08B1 - Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Duarte : City of Hope Updated

COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymhoblastic Leukemia (ALL)

Duarte : City of Hope Updated

Immune Responses in Acute Leukemia and Chronic Myeloid Leukemia

Duarte : City of Hope Updated

Mechanisms of Response and Resistance to STI571 in CML

Duarte : City of Hope Updated

Molecular Pathogenesis of Acute Leukemia and Myelodysplasia

Duarte : City of Hope Updated

Molecular Pathogenesis of Therapy-Related Leukemia

Duarte : City of Hope

SWOG 9007: Cytogenetic Studies In Leukemia Patients

Duarte : City of Hope Updated

SWOG S0805: Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) with or without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL) (A BMT Study)

Duarte : City of Hope Updated

SWOG S0910: A Phase II Study of Epratuzumab (NSC-716711) in Combination with Cytarabine and Clofarabine for Patients with Relapsed or Refractory Ph-Negative Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)

View More »

Anaheim : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Anaheim : Pacific Cancer Medical Center, Inc

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Burbank : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Burbank : East Valley Hematology and Oncology Medical Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Concord : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Concord : Bay Area Cancer Research Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Duarte : City of Hope

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Duarte : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Duarte :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Escondido : Southwest Cancer Care Medical Group

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Escondido : Southwest Cancer Care Medical Group

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Fountain Valley : Lalita Pandit, MD, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Fountain Valley : Pacific Coast Hematology/Oncology Medical Group, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Fountain Valley : Robert A. Moss, M.D. FACP, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Glendora : Wilshire Oncology Medical Group, Inc

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Hayard : Kaiser Permanente Northern California

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

La Jolla : Site Reference ID/Investigator# 48325

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma

La Jolla : Univ. of San Diego: Moores UCSD Cancer Center

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

La Jolla :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

La Jolla : Scripps Cancer Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

La Jolla : Scripps Cancer Center

A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

La Jolla : University of California, San Diego

Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

La Jolla : University of California San Diego

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

La Jolla : Danelle James, M.D.

Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)

La Jolla : University of California San Diego, Moores Cancer Center

Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)

La Jolla : University of California San Diego Moores Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

La Jolla : Moores UCSD Cancer Center Updated

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

La Jolla : University of San Diego Medical Center Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

La Jolla : UCSD Medical Center

Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)

La Jolla : Scripps Cancer Center Clinical Research

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

La Jolla : Moores Cancer Center

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

La Jolla : Moores UCSD Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

LaVerne : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Long Beach : Jonathan Jaques Children'S Cancer Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Long Beach : Miller Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Los Angeles : UCLA

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Los Angeles : Childrens Hospital Los Angeles

A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Los Angeles :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Los Angeles : UCLA Ronald Reagan Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Los Angeles : Childrens Hospital Los Angeles

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Los Angeles : University of Southern California

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Los Angeles : Cedars-Sinai Medical Center

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Los Angeles : USC Norris Cancer Center/LAC USC Medical Center

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Los Angeles : UCLA

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Los Angeles : Childrens Hospital Los Angeles

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Los Angeles : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Los Angeles : Metropolitan Hematology Oncology Medical Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Los Angeles : UCLA Division of Hematology-Oncology

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Los Angeles : Usc - Norris Comprehensive Cancer Center And Hospital

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Los Angeles : Ucla-Division Of Hematology/Oncology

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Los Angeles : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Los Angeles : UCLA School of Medicine, Division of Hematology/Oncology

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Los Angeles : USC/Norris Comprehensive Cancer Center and Hospital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Los Angeles : UCLA Division of Hematology/Oncology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Los Angeles : UCLA

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Los Angeles : University of Southern California

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Los Angeles : Childrens Hospital Los Angeles

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Madera :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Murrieta : Southwest Cancer Center

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Oakland : Oakland Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Oceanside : North County Oncology

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Orange : Children'S Hospital Of Orange County

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Orange : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Orange : Children'S Hospital Of Orange County

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Orange : Children's Hospital of Orange County

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Oxnard : Ventura County Hematology Oncology Specialists

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Oxnard : PMK Medical Group, Inc. DBA Ventura

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Palo Alto : Stanford Cancer Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Palo Alto : Stanford University Medical Center

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Palo Alto : Stanford Cancer Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Palo Alto : Stanford University Medical Center

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Pasadena :

A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Rancho Mirage : Cancer and Blood Institute Medical Group

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Rancho Mirage : Desert Hematology Oncology Medical Group, Inc.

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Sacramento : Univeristy of California Davis Medical Center

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

San Diego : Kaiser Permanente Medical Group Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

San Diego : Rady Children's Hospital

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

San Diego : Moores UCSD Cancer Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

San Diego : Sharp Clinical Oncology Research

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Francisco : UCSF School of Medicine

A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

San Francisco : University Of California Medical Center

Dasatinib Combo With SMO Inhibitor (BMS-833923)

San Francisco : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

San Francisco : UCSF Helen Diller Family Family Comprehensive Cancer Center

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

San Francisco : University of California Medical Center Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

San Francisco : University of California San Francisco

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Francisco : UCSF School of Medicine

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

San Luis Obispo : (200) Coastal Integrative Cancer Care

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

San Pablo : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Santa Monica, : Sarcoma Oncology Center

Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia

Stanford : Stanford University Cancer Institute

A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

Stanford :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Stanford : Investigational Site

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Stanford : Stanford Cancer Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Stanford : Stanford University

A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)

Stanford : Stanford University School of Medicine

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Stanford : Stanford University School of Medicine

Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)

Stanford : Stanford University Medical Center

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Stanford : Stanford University School of Medicine

Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

Stanford : Stanford University School of Medicine

Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

Stanford : Stanford University School of Medicine

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

Stanford : Stanford Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Stanford : Stanford University Medical Center

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Stanford : Stanford University Medical Center Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Stanford : Stanford University School of Medicine

Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Stanford : Stanford University Medical Center, BMT

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Stockton : St. Teresa Comprehensive Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Vista : Medical Group of North County

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Yorba Linda : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Aurora : Children'S Hospital

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Aurora : (115) University of Colorado Anschultz Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

Aurora : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Aurora : Rocky Mountain Cancer Centers

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Aurora :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

View More »

Aurora : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Aurora : Investigational Site Number 840004

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

Boulder : Rocky Mountain Cancer Centers

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Colorado Springs : The Oncology Clinic, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Denver :

A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Denver : Investigational Site

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Denver : Rocky Mountain Cancer Centers - Denver

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Denver : Mile High Oncology

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Denver : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Denver : Rocky Mountain Blood and Bone Marrow Transplant Program

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Denver : HCA HealthONE - Rocky Mountain Blood and Marrow Transplant Program

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Denver : Rocky Mountain Cancer Centers

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

Hartford : Connecticut Children'S Medical Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Manchester : Medical Oncology and Blood Disorders, LLP

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New Britain : The Hospital of Central Connecticut

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

New Haven : Yale Cancer Center

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia

New Haven : Yale Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

View More »

Norwalk : Norwalk Hospital Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Southington : Cancer Center of Central Connecticut Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Southington : Cancer Center of Central Connecticut Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Southington : Cancer Center of Central Connecticut

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Southington : Cancer Center of Central Connecticut

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Wilmington : A. I. Dupont Hospital For Children

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Fort Lauderdale : Holy Cross Hospital

VOS-AML-301

View More »

Atlantis : Medical Specialists of the Palm Beaches

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Aventura : Aventura Healthcare Associates

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Boca Raton : Boca Raton Community Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Boynton Beach : Collaborative Research Group

A Extension Study of GS-1101 for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116

Boynton Beach : Collaborative Research Group LLC

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Boynton Beach : University Cancer Institute

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Boynton Beach : Thomas Niederman, MD

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Boynton Beach : Palm Beach Institute of Hematology and Oncology

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Boynton Beach : Hematology And Medical Oncology Of Southern Palm Beach County

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Fort Lauderdale : Holy Cross Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Fort Meyers : Investigational Site Number 840104 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Fort Myers : Florida Cancer Specialists

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL

Gainesville : Shands at the University of Florida

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Hialeah : Palm Springs Research Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Jacksonville : Mayo Clinic Jacksonville

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Jacksonville : Integrated Community Oncology Network

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Jacksonville : Mayo Clinic

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Jacksonville : Nemours Children'S Clinic

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Jacksonville : Integrated Community Oncology Network

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Jacksonville : Baptist Cancer Institute

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Jacksonville : Baptist Cancer Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Kissimmee : Osceola Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Miami :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Miami : Advanced Medical Specialties

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Miami : University of Miami Cancer Center

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Miami Beach : (145) Mount Sinai Comprehensive Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

Miami Beach : Mount Sinai Comprehensive Cancer Centers

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

New Port Richey : Florida Cancer Institute - New Hope

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

New Port Richey : Pasco Hernando Oncology Associates (Kumar)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

New Port Richey : Pasco Hernando Oncology Associates, PA

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Port Richey : Pasco Pinellas Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Port Richey : Florida Cancer Specialists

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Ocala : Ocala Oncology Center

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Orlando : Cancer Centers of Florida

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Orlando : Florida Hospital Cancer Institute

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL

Orlando : Cancer Centers of Florida

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Pembroke Pines : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Pensacola : Investigational Site Number 840016 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Pensacola : Woodlands Medical Specialists

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Sarasota :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Stuart : Martin Memorial Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Tampa :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL)

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

Tampa : Moffitt Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

Tampa : Call for Information (Investigational Site 0006) Updated

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)

Tampa : Moffitt Cancer Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Tavares : Lake County Oncology and Hematology Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Tavares : Lake County Oncology & Hematology

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Tavares : Lake County Oncology and Hematology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Titusville : Space Coast Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

West Palm Beach : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Weston : Cleveland Clinic Florida Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Savannah : Memorial Health University Medical Center

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Savannah : Memorial Health University Medical Center

Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer SWOG S9910

Savannah : Memorial Health University Medical Center

Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes CALGB 9665

Savannah : Memorial Health University Medical Center

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer COG ABTR01B1

Savannah : Memorial Health University Medical Center

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia COG AALL0331

Savannah : Memorial Health University Medical Center

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia COG AAML0631

Savannah : Memorial Health University Medical Center

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia COG AALL0434

Savannah : Memorial Health University Medical Center

Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia COG AAML0531

Savannah : Memorial Health University Medical Center

Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia COG AALL0631

Savannah : Memorial Health University Medical Center

Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Savannah : Memorial Health University Medical Center

Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia COG ADVL04P2

Savannah : Memorial Health University Medical Center

Erwinase Master Treatment Protocol (EMTP)

Savannah : Memorial Health University Medical Center

Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia. COG AALL08B1

Savannah : Memorial Health University Medical Center

Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia AALL03B1

Savannah : Memorial Health University Medical Center

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia CALGB 20203

Savannah : Memorial Health University Medical Center

Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers SWOG S9007

Savannah : Memorial Health University Medical Center

Trial NCT00437060 A Study of Neurocognitive Function in Children Treated for ALL AALL06N1

View More »

Albany : Phoebe Putney Memorial Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Atlanta : Emory University Winship Cancer Institute

A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)

Atlanta : Aflac Cancer Center & Blood Disorders Service

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Atlanta : Emory University, Winship Cancer Institute

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Atlanta : Emory University, Winship Cancer Institute

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Atlanta :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Atlanta : Winship Cancer Institute, Emory University Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Atlanta : Blood and Marrow Transplant Group of Georgia Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Atlanta : Northside Hospital/BMTGA

A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)

Atlanta : Site Reference ID/Investigator# 26523 Updated

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Atlanta : Georgia Cancer Specialists

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Atlanta : Peachtree Hematology-Oncology Consultants

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Atlanta :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Atlanta : Winship Cancer Institute

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Atlanta : The Blood and Marrow Transplant Group of GA

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Atlanta : Winship Cancer Institute at Emory

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Atlanta : Emory University

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Atlanta : Children's Healthcare of Atlanta, Emory University

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Augusta : Investigational Site Number 840006 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Augusta : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Augusta : Augusta Oncology Associates, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Augusta : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Augusta : Investigational Site Number 840006

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

Augusta : Georgia Health Sciences University

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Dublin : US Oncology - Dublin Hematology & Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Griffin : Spalding Oncology Services

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Marietta :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Marietta : Northwest Georgia Oncology Centers, PC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Sandy Springs : Georgia Cancer Specialist

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Savannah : Lewis Cancer Center and Research Pavilion

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Honolulu : Straub Clinic and Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Honolulu : Straub Clinical & Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Boise : St Luke's Mountain States Tumor Institute

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Post Falls : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Arlington Heights : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Chicago : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Chicago : University of Chicago

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Chicago : Children'S Memorial Hospital

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Chicago : Northwestern Univ. Med School

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

View More »

Chicago : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Acute Leukemia

Chicago : Northwestern Memorial Hospital Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Chicago : The University of Chicago Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Chicago : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Chicago : University of Chicago Cancer Center

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Chicago : Northwestern University

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Chicago : Northwestern University Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Chicago : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Chicago : Northwestern University

Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

Chicago : John H. Stroger Hospital of Cook County

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Chicago : University of Chicago

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Chicago : University of Chicago

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Chicago : John H. Stroger, Jr., Hospital of Cook County

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Chicago : Rush University Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Chicago : Northwestern University Feinberg School of Medicine

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Chicago : Rush University Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Chicago : University of Chicago Cancer Research Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Chicago : Northwestern University

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Chicago : Robert H. Lurie Comprehensive Cancer Center Northwestern University

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Chicago : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Chicago : Northwestern University

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Chicago : Rush University Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Chicago : University of Chicago Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Chicago : Children's Memorial Hospital

Reduced Intensity Transplant Using Extracorporeal Photopheresis

Chicago : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Chicago : Northwestern University

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Chicago : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Chicago : Northwestern University

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Chicago : Rush University Medical Center

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Chicago : Robert H. Lurie Comprehensive Cancer Center

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Chicago : Rush University Medical Center

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Chicago : Univerity of Chicago

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Chicago : University of Chicago Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Chicago : University of Chicago

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Chicago : Rush University Medical Center, Division of Hematology/Oncology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Evergreen Park : Mahafzah Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Gurnee : Oncology Hematology Assoc. of Northern Illinois

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Harvey : Ingalls Cancer Research Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Hines : Edward Hines Jr. VA Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Lombard : Elmhurst Memorial Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Maywood : Investigational Site Number 840011 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Maywood : Loyola University, Cardinal Bernardin Cancer Center

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Maywood : Loyola University Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Niles : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Niles : Oncology Specialists, S.C.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Niles : Orchard Health Care Research

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

North Chicago : North Chicago VA Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

North Chicago : North Chicago VA Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

North Chicago : North Chicago VA Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Peoria : Illinois Cancer Care

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Skokie : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Skokie : Hematology Oncology Assoc. of IL. Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Skokie : Orchard Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Skokie : Edward H. Kaplan MD & Associates

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Urbana : Carle Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Winfield : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Anderson : Saint John's Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Beech Grove : Indiana Blood and Marrow Transplantation

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Beech Grove : St. Francis Cancer Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Beech Grove : Indiana Blood and Marrow Transplantation, LLC Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Beech Grove : Indiana Blood and Marrow Transplantation

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

View More »

Goshen :

A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Goshen : Center for Cancer Care @ Goshen Health Systems

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Indianapolis : St. Francis Medical Group Oncology and Hematology Specialits Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Indianapolis : Hematology Oncology of Indiana, PC

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Indianapolis : Indiana University Simon Cancer Center IU Simon Cancer Center Clinical Research Office, RT 380

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Indianapolis : Indiana University Cancer Center Clinical Research Office

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Indianapolis : Indiana Oncology Hematology Consultants

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Pilot Study of Erlotinib for the Treatment of Patients With de Novo Acute Myeloid Leukemia

Indianapolis : St. Francis Hospital and Health Center

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Indianapolis : St. Francis Medical Group Oncology and Hematology Specialists

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Lafayette : Horizon Oncology Center

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Lafayette : Arnett Cancer Care

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Lafayette : Horizon Oncology Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Mishawaka : Cancer Care Partners, LLC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

New Albany : Cancer Care Center, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

New Albany : Cancer Care Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Albany : Cancer Care Center Inc.

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

New Albany : Cancer Care Center, Inc. PC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Ames : McFarland Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bettendorf : Hematology Oncology Associates of the Quad Cities

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cedar Rapids : Iowa Blood and Cancer Care of PCI

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Iowa City : University of Iowa Hopsitals

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Iowa City : University of Iowa Hospitals and Clinics

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

View More »

Mason City : N. Iowa Mercy Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Waterloo : Covenant Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Hutchinson : Hutchinson Clinic

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Kansas City : University of Kansas Medical Center, Westwood Campus

Safety Study: Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia

Kansas City : University of Kansas Medical Center

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Topeka : Cotton O'Neil Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Westwood : University of Kansas Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

View More »

Westwood : University of Kansas Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Wichita : Cancer Center of Kansas, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Wichita : Cancer Center of Kansas

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Witchita : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Hazard : Kentucky Cancer Clinic

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Lexington : Investigational Site Number 840013 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Lexington : Central Baptist Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Paducah : Investigational Site Number 840007 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Paducah : Purchase Cancer Group

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Baton Rouge : Mary Bird Perkins Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Metairie : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

New Orleans : (195) Tulane University Hospital Tulane Cancer Center

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

New Orleans : Ochsner Medical Institutions Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

New Orleans : Tulane University Health Sciences Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

View More »

New Orleans : Ochsner Clinic Foundation

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Shreveport : LSU Health Sciences Center,

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Shreveport : Willis-Knighton Cancer System

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Baltimore : University of Maryland Greenbaum Cancer Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Baltimore : Johns Hopkins Medical Institute

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Baltimore : St. Agnes Hospital

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Baltimore : Sidney Kimmel Cancer Center At Johns Hopkins

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Baltimore :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

View More »

Baltimore : Chesapeake Oncology Hematology Associates

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Baltimore : Auerbach Hematology Oncology Associates, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Baltimore : Greater Baltimore Medical Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Baltimore : B. Douglas Smith, M.D.

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Baltimore : Johns Hopkins Kimmel Cancer Center

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Baltimore : Johns Hopkins University

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Baltimore : Johns Hopkins Hospital

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Baltimore : University of Maryland Greenebaum Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Baltimore : Sidney Kimmel Comprehensive Cancer Center

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Baltimore : Call for Information (Investigational Site 0001) Updated

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Baltimore : Johns Hopkins University

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Bethesda : National Cancer Institute Updated

A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia

Bethesda : Center for Cancer & Blood Disorders, PC

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Bethesda : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Bethesda : Center for Cancer and Blood Disorders

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL

Bethesda : National Capital Clinical Research Consortium

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL

Bethesda : Center for Cancer and Blood Disorders

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Boston :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Columbia : Maryland Oncology Hematology Pa

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Cumberland : Western Maryland Health System, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Westminster : Alliance Hematology Oncology, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Boston : Site Reference ID/Investigator# 48324

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma

Boston : Dana-Farber Cancer Institute

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Boston :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Boston : Investigational Site Number 840004 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Boston : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

View More »

Boston : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Boston : Dana-Farber Cancer Institute

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Boston : Beth Israel Deaconess Medical Center

Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)

Boston : Beth Israel Deaconess Medical Center

Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

Boston : Dana-Farber Cancer Institute

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Boston : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Boston : Dana Farber Cancer Institute and Children's Hospital

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Boston : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Boston : Dana-Farber Cancer Institute

Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Boston : Massachusetts General Hospital

Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Boston :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Boston : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Boston : Dana Farber Cancer Institute

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Boston : Dana-Farber Cancer Institute

Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

Boston : Dana Farber Cancer Institute

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Boston : Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Boston : Dana Farber Cancer Institute

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Boston : Dana-Farber Cancer Institute

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Boston : Beth Israel Deaconess Medical Center

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Boston : Massachusetts General Hospital

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Boston : Dana Faber Cancer Institute

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Boston : Research Site

Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients

Boston : Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program

Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit

Boston : Massachusetts General Hospital

Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit

Boston : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Boston : Brigham & Women's Hospital

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Boston : Dana Farber Cancer Institute

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Boston :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Boston : Beth Israel Deaconess Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Boston : Dana-Farber Cancer Institute

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Boston : Massachusetts General Hospital

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Boston : Massachusetts General Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Boston : Dana Farber Cancer Institute

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Boston : Beth Israel Deaconess Medical Center

Treatment of Older Adults With Acute Lymphoblastic Leukemia

Boston : Massachusetts General Hospital

Treatment of Older Adults With Acute Lymphoblastic Leukemia

Boston : Dana-Farber Cancer Institute

Treatment of Older Adults With Acute Lymphoblastic Leukemia

Boston : Dana Farber Cancer Institute

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Boston : Dana Farber

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Concord : Commonwealth Hematology-Oncology, P.C.

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Hyannis : Capecod Hospital / Davenport Mugar Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Wocester :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Worcester : Fallon Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Worcester : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Worcester : University of Massachusetts Memorial Medical Center Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Ann Arbor : Investigational Site

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Ann Arbor : University Of Michigan Health System

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Ann Arbor : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Ann Arbor : University of Michigan Comprehensive Cancer Center

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

Ann Arbor : University of Michigan Cancer Center

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

View More »

Ann Arbor : University of Michigan Comprehensive Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Ann Arbor : University of Michigan,Department of Internal Med. Hematology- Oncology

Stem Cell Transplantation To Treat High Risk Lymphoid Diseases With Reduced Toxicity Myeloablative Conditioning Regimen

Ann Arbor :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Ann Arbor : University of Michigan Health System

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Ann Arbor : University of Michigan

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Ann Arbor : C.S. Mott Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Detroit : Karmanos Cancer Institute

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Detroit : Henry Ford Health System Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Detroit : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Detroit : Children's Hospital of Michigan

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Detroit : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Detroit : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Detroit : Karmanos Cancer Institute

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Detroit : Henry Ford Health System

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Farmington Hills : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Flint : Michigan State University / McLaren Regional Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Flint : Genesee Cancer & Blood Disease Treatment Center, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Freesoil : West Michigan Regional Cancer & Blood Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Grand Rapids : Cancer and Hematology Centers of Western Michigan

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Grand Rapids : Spectrum Health Hospitals

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Kalamazoo : West Michigan Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kalamazoo : West Michigan Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Southfield : Providence Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Duluth : Duluth Clinic Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Minneapolis : University of Minnesota

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Minneapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Acute Leukemia

Minneapolis : Masonic Cancer Center, University of Minnesota

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Minneapolis : Masonic Cancer Center, University if Minnesota

Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

View More »

Minneapolis : Minnesota Oncology Hematology P.A.

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Minneapolis : University of Minnesota Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Minneapolis : Division of Hematology, Oncology and Transplantation University of Minnesota

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Minneapolis : Childrens Hospital & Clinics of Minnesota

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Minneapolis : University of Minnesota Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Rochester : Mayo Clinic Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Rochester : Mayo Clinic Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Rochester : Mayo Clinic

Clinical Study of PM01183 in Patients With Acute Leukemia

Rochester :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Rochester : Mayo Clinic

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Rochester : Mayo Clinic

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

St. Louis Park : Park Nicollet Institute - Louisiana Ave.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

St. Louis Park : Park Nicollet Institute Metro - MN CCOP

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Jackson : Univ Of Mississippi Med Ctr

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Southaven : US Oncology - University of Tennessee Cancer Institute - Southaven

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Branson : Branson Oncology Clinic

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Columbia : US Oncology - Missouri Cancer Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Columbia : Ellis Fischel Cancer Center, University of Missouri Health Care

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Jefferson City : Capitol Comprehensive Cancer Care Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kansas City : Saint Luke's Cancer Institute Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

View More »

Saint Louis : Saint Louis University Cancer Center - Division of Hematology Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Springfield : St. John's Medical Research Institute

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Springfield : St John's Clinic for Cancer and Hematology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

St Louis : Investigational Site Number 840015 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

St. Joseph : St. Joseph Oncology, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

St. Louis : Washington University School of Medicine

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

St. Louis : (100) Washington University School of Medicine

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

St. Louis : St. Louis University Cancer Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

St. Louis : St Louis University

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

St. Louis : Washington University School of Medicine

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

St. Louis : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

St. Louis : Hematology Oncology Consultants, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

St. Louis : St. Louis Hematology Oncology Specialists, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

St. Louis : Saint Louis Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

St. Louis :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

St. Louis : Washington University at St. Louis Siteman Cancer Center

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

St. Louis : Washington University School of Medicine

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Billings : (150) Billings Clinic

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

Billings : Billings Clinic

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Missoula : Montana Cancer Institute Foundation

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lincoln : Nebraska Hematology Oncology, PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Omaha : Nebraska Methodist Hospital

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Omaha : Univ. of Nebraska Medical Center

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Omaha : University of Nebraska Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

View More »

Omaha : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Omaha : University of Nebraska Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Omaha : University of Nebraska Medical Center

Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma Following Donor Stem Cell Transplant

Omaha : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Carson City : Sierra Nevada Oncology Care

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Henderson : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Las Vegas : Comprehensive Cancer Centers of Nevada

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Las Vegas : Southern Nevada Cancer Research Foundation

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Las Vegas : Nevada Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

View More »

Las Vegas : Children'S Specialty Center Of Nevada

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Las Vegas : Nevada Cancer Research Foundation

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Las Vegas : Comprehensive Cancer Centers of Nevada

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

Reno : VA Sierra Nevada Healthcare System

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lebanon : Dartmouth - Hitchcock Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Lebanon : Dartmouth-Hitchcock Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Portsmouth : Portsmouth Regional Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Cherry Hill : The Center for Cancer and Hematologic Disease

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cherry Hill : The Center for Cancer and Hematologic Disease

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Denville : Cancer Care at Saint Clare's/Saint Clares Hospital Oncology & Hematology Specialists, P.A.

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Denville : Oncology & Hematology Associates

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Elizabeth : Ellioth Fishkin, MD

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

View More »

Englewood : Drs. Forte, Schleider, Attas & Condemi, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Hackensack : Hackensack University Medical Center

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Hackensack : Hackensack University Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Hackensack : John Theurer Cancer Center at the Hackensack University Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Hackensack : Investigational Site

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Hackensack : Hackensack University Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Hackensack : Research Site

AMG 319 Lymphoid Malignancy FIH

Hackensack : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Hackensack : The Cancer Center at Hackensack University Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Hackensack : John Theurer Cancer Center

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Hackensack : Hackensack University Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Hackensack : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Hackensack : Hackensack University Medical Center

Study Examining the Combination of Lenalidomide and Azacitidine for Relapsed/Refractory CLL and SLL

Hackensack : Northern New Jersey Cancer Associates

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Hackensack : Hackensack University Medical Center

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Hackensack : The Cancer Center, Hackensack University Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hackensack : Hackensack University Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Morristown : Hematology Oncology Associates of Northern NJ

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Morristown : Charles Farber, MD

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Morristown : Hematology Oncology of Northern New Jersey

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Morristown : Hematology-Oncology Associates of Northern NJ, PA

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Somerville : Steeplechase Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Somerville : Somerset Hematology Oncology Associates

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Summit : Overlook Hospital

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Vineland : Southern Oncology Hematology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Albuquerque : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Acute Leukemia

New Hyde Park : Biomedical Research Alliance of New York

Leukemia

View More »

Albany : Samuel S Stratton VAMC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bay Shore : Hematology Oncology Associates of Western Suffolk

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bronx : Children's Hospital at Montefiore

A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer

Bronx : Eastchester Center for Cancer Care

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bronx : Bronx River Medical Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bronx : Albert Einstein College of Medicine

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Bronx : Montefiore Medical Center

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Bronxville : Eduardo Saponara, MD

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Buffalo :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Buffalo : Roswell Park Cancer Institute

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Buffalo : Jonah Cancer Care Center & ECMC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Buffalo : Roswell Park Cancer Institiute

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Buffalo : Roswell Park Cancer Institute

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Buffalo : Roswell Park Cancer Institute

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Buffalo : Roswell Park Cancer Institute

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Buffalo : Roswell Park Cancer Institute

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Buffalo : Roswell Park Cancer Institute

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Hawthorne : Westchester Hematology Oncology Group, PC Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Hawthorne : New York Medical College

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Johnson City : Broome Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Johnson City : Broome Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Lake Success : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Lake Success : North Shore - LIJ Health System

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Lake Success : North Shore Long Island Jewish Health System

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Mount Kisco : Westchester Hematology Oncology Associates

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

New Hyde Park : North Shore University Hospital

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

New Hyde Park : Long Island Jewish Medical Center

A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

New Hyde Park : Long Island Jewish Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

New Hyde Park :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

New Hyde Park : Long Island Jewish Medical Center

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

New Hyde Park : Long Island Jewish Medical Center Biomedical Research Alliance of NY (BRANY)

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

New Hyde Park : Long Island Jewish Medical Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

New York : Weill Cornell Medical College

A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)

New York : Stephen D. Hassenfeld Children'S Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

New York : Mount Sinai Medical Center

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

New York : Beth Israel Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

New York : Memorial Sloan Kettering Cancer Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

New York : Cornell University

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

New York : Memorial-Sloan Kettering Cancer Center

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

New York : Memorial Sloan Kettering Cancer Center

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

New York : Columbia Presbyterian Medical Center

Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL

New York : Weill Medical College of Cornell

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

New York : Weill Cornell Medical College

Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)

New York : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

New York : Mount Sinai School of Medicine & Mount Sinai Graduate School of biological Sciences

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

New York : Memorial Sloan-Kettering Cancer Center

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

New York : Columbia University Medical Center

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

New York : Memorial Sloan-Kettering Cancer Center

Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

New York : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

New York : New York Presby Hospital, Weill Medical College at Cornell University

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York : Mount Sinai Medical Center

Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)

New York : Weill Cornell Medical College

Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies

New York : Memorial Sloan-Kettering Cancer Center

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

New York : Weill Cornell Medical College

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

New York : Memorial Sloan-Kettering

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

New York : New York Presbyterian Hospital, Weill-Cornell Medical College

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

New York : Memorial Sloan-Kettering Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York : Weill Cornell Medical College

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

New York : Memorial Sloan Kettering Cancer Center

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

New York : Weill Medical College of Cornell

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

New York : Advanced Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New York : Memorial Sloan Kettering Cancer Center

Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies

New York : Children's Hospital New York-Presbyterian

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

New York City : New York Hospital Weill Cornell Medical Center

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Rochester :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Rochester : Interlakes Oncology Hematology, PC

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Rochester : University of Rochester Medical Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Rochester : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Rochester :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Stony Brook : Stony Brook University Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Stony Brook : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Stony Brook : Stony Brook University Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Stony Brook : Stony Brook University Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Syracuse : SUNY Upstate Medical University Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Syracuse : SUNY Upstate Medical University - Adult Program

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Syracuse : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Valhalla : New York Medical College

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Valhalla : New York Medical College, Division of Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Valhalla : New York Medical College, Division of Oncology/Hematology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Cary : US Oncology - Cancer Centers of North Carolina - Cary

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cary : Waverly Hematology Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Chapel Hill : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Chapel Hill : University of North Carolina at Chapel Hill

PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias

Chapel Hill : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

View More »

Chapel Hill : University of North Carolina Hospitals

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Charlotte :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Charlotte : Levine Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Charlotte : Mecklenburg Medical Group

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Charlotte : Levine Children's Hospital at Carolinas Medical Center

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Durham : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Acute Leukemia

Durham : Duke University Medical Center

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Durham : Duke University Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Durham : Duke University

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Durham : Research Site

AMG 319 Lymphoid Malignancy FIH

Durham : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Durham : Duke University Medical Center

Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Durham : Duke University Medical Center

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Durham : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Durham : Duke University Medical Center

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Durham : Duke University Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Durham : Duke University Medical Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Durham : Duke University Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Gastonia : Gaston Hematology Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Greenville : East Carolina University

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

New Bern : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Raleigh : Raleigh Hematology Oncology Associates

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Raleigh : US Oncology - Cancer Centers of North Carolina - Falls

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Raleigh : US Oncology - Cancer Centers of North Carolina - Macon

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Winston-Salem : Wake Forest University Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Winston-Salem : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Winston-Salem : Wake Forest University, Health Sciences Section on Hematology and Oncology

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Winston-Salem : Wake Forest University School of Medicine

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Winston-Salem : Wake Forest University Health Sciences

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Winston-Salem : Wake Forest University Health Sciences

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bismarck : Legacy Pharma Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bismarck : Mid Dakota Clinic/Odyssey Research

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Fargo : Roger Maris Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

(ADVL0812) A Phase I Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children with Relapsed/Refractory Solid Tumors and Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

A Feasibility Pilot and Phase 2 Study of Chemoimmunotherapy with Epratuzumab for Children with Relapsed CD22-Positive Acute Lymphoblastic Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

ADVL0816: A Phase I Study of Obatoclax (Pan Anti-Apoptotic BCL-2 Family Small Molecule Inhibitor), in Combination with Vincristine/Doxorubicin/Dexrazoxane, in Children with Relapsed/Refractory Solid Tumors or Leukemia

View More »

Akron : Summa Health System - Cancer Research Office

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Akron : Summa Health System Hospitals

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Akron : Akron General Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Canton : Investigational Site Number 840014 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Canton : Gabrail Cancer Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Canton : Gabrail Cancer Center Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Canton : Nashat Y. Gabrail, MD, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Canton : Gabrail Cancer Center Research

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Canton : Gabrail Cancer Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Cincinnati : The Christ Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Cleveland : Cleveland Clinic Foundation Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Cleveland : Case Western Reserve University Hospitals of Cleveland Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Cleveland : University Hospitals Case Medical Center

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Cleveland : Cleveland Clinic

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Cleveland : Cleveland Clinic Taussig Cancer Center

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Cleveland : Cleveland Clinic

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Cleveland : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Cleveland : Case Western Reserve University, University Hospitals of Cleveland

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : Cleveland Clinic, Taussig Cancer Institute

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : Cleveland Clinic Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Cleveland : University Hospitals Case Medical Center Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Cleveland : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Cleveland : The Cleveland Clinic Foundation

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Cleveland :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Cleveland : University Hospitals fo Cleveland

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Columbus : James Cancer Hospital

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

Columbus : Ohio State University Medical Center

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Columbus : The Ohio State University James Cancer Hospital

Bortezomib and Midostaurin With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Columbus : Mid Ohio Oncology / Hematology, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Columbus :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Columbus : Nationwide Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Columbus : Ohio State Comprehensive Cancer Center/James Cancer Hospitial/ClinicalTrials Center

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Columbus : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Columbus : Ohio State Univeristy Comprehensive Cancer Center

Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit

Columbus : Ohio State University Medical Center

Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Columbus : Nationwide Childrens Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Dayton : Research Site

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Elyria : Hematology Oncology Center, Inc.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Middletown : Signal Point Clinical Research Center, LLC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Newark : Medical Center of Newark

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Oklahoma City : University of Oklahoma Health Science Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Oklahoma City : University of Oklahoma Health Sciences Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Tulsa : Cancer Care Associates

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Eugene :

A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Eugene : Willamette Valley Cancer and Research / USOR

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Eugene : US Oncology - Willamette Valley Cancer Institute - Eugene

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : Oregon Health & Sciences University

A Phase I Study of GNKG186 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Portland : Oregon Health & Sci Univ

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

View More »

Portland : Oregon Health and Science University

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Broadway

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Hoyt

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Portland : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Portland : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Portland : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Portland : Legacy Emanuel Hospital & Health Center

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Portland : Oregon Health & Science University

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Springfield : US Oncology - Willamette Valley Cancer Institute - Springfield

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Springfield : US Oncology Research: Willamette Valley Cancer Institute and Research Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Springfield : Willamette Valley Cancer Institute and Research Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Tualatin : US Oncology - Northwest Cancer Specialists, PC - Tualatin

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Tulatin : Northwest Cancer Specialists, P.C.

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Bethlehem : Oncology Hematology of Lehigh Valley

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Drexel Hill : Consultants in Medical Oncology and Hematology, PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Gettysburg : Gettysburg Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Harrisburg : Andrews and Patel Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Hershey : Penn State Milton S. Hershey Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

View More »

Hershey : Penn State Milton S. Hershey Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Hershey : Penn State Hershey Cancer Institute

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Kingston : US Oncology - Medical Oncology Associates (Nahar)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kingston : Medical Oncology Associates of Wyoming Valley, PC

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Lancaster : Lancaster Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lancaster : Lancaster General Health

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Norristown : Luitpold Pharmaceuticals, Inc.

Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia

Philadelphia : Children'S Hospital Of Philadelphia

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Philadelphia : Fox Chase Cancer Center

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Philadelphia : Investigational Site Number 840001 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Philadelphia : Abramson Cancer Center of the University of Pennsylvania Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Philadelphia : Thomas Jefferson University

Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma

Philadelphia : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Philadelphia : Hospital of the University of Pennsylvania

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Philadelphia : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Philadelphia : University of Pennsylvania, Abramson Cancer Center

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Philadelphia : Children's Hospital of Philadelphia

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Philadelphia : Drexel University, College of Medicine

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Philadelphia : Drexel University College of Medicine

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Philadelphia : Hospital of the University of Pennsylvania

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Philadelphia : Temple University at Jeanes Hospital

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Philadelphia : Abramson Cancer Center of the University at Perlman Center for Advanced Medicine

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Philadelphia : Thomas Jefferson University

Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias

Pittsburgh : Western Pennsylvania Hospital

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Pittsburgh : Children'S Hospital Of Pittsburgh

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Pittsburgh : (160) The Western Pennsylvania Hospital- Cancer Institute

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

Pittsburgh : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Pittsburgh : The Western Pennsylvania Hospital Updated

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Post-remission Chemotherapy for Leukemia

Pittsburgh : Western Pennsylvania Hospital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Pittsburgh : Veterans Research Foundation of Pittsburgh

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Pottstown : Pottstown Memorial Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Reading : Berks Hematology Oncology Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

West Reading : Berks Hematology-Oncology Associates

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Wilkes Barre : Geisinger Health System

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Willow Grove : Abington Hematology Oncology Associates Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Cranston : Hematology & Oncology Associates of Rhode Island

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Cranston : Sambandam and Joseph Associates, Inc

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Cranston : Hematology and Oncology Associates of RI

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Charleston : Charleston Hematology Oncology Associates, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Charleston : Charleston Hematology Oncology, PA

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Charleston : Medical University of South Carolina

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Charleston : Medical University of South Carolina/Clinical Trials Office

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Charleston : Investigational Site Number 840002

Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

View More »

Charleston : Charleston Hematology and Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Charleston : Medical University of South Carolina

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Charleston : Medical University of South Carolina

Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab

Columbia : Liberty Hematology Oncology Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Columbia : South Carolina Oncololgy Associates, PA

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Columbia : South Carolina Oncology Associates

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Columbia : South Carolina Oncology Associates, PA

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL

Easley : US Oncology - Cancer Centers of the Carolinas - Easley

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : Saint Francis Hospital

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Greenville : US Oncology - Cancer Centers of the Carlinas - Eastside

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : US Oncology - Cancer Centers of the Carolinas - Butternut

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : US Oncology - Cancer Centers of the Carolinas - West Faris

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Greenville : Bon Secours St. Francois Health System

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Greenville : St. Francis Hospital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Greenville : Greenville Hospital System

Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab

Hilton Head Island : South Carolina Cancer Specialists

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Seneca : US Oncology - Cancer Centers of the Carolinas - Seneca

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spartanburg : US Oncology - Cancer Centers of the Carolinas - Spartanburg

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Sioux Falls : (120) Avera Cancer Institute

A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age

Sioux Falls : Sanford Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Watertown : Prairie Lakes Healthcare System, Inc

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Bartlett : US Oncology - University of Tennessee Cancer Institute - Bartlett

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Collierville : Family Cancer Center, PLLC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Collierville : The Family Cancer Center

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Germantown : The Jones Clinic

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Germantown : US Oncology - University of Tennessee Cancer Institute - Germantown

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Germantown : C. Michael Jones, MD, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Knoxville : Tennessee Cancer Specialists

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Memphis : St. Jude Children's Research Hospital Updated

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

Memphis : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Memphis : St. Jude Children's Research Hospital

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Memphis : US Oncology - University of Tennessee Cancer Institute - Memphis

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Memphis : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Memphis : Family Cancer Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Memphis : St. Jude

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Nashville : Sarah Cannon Research Institute

A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer

Nashville : Sarah Cannon Research Institute Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Nashville :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Nashville : Vanderbilt University Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Nashville : Sarah Cannon Research Institute

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Nashville : Novartis Investigative Site

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Nashville : SCRI

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Nashville : Vanderbilt U Medical Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Nashville : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Nashville : Tennessee Oncology, PLLC

Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL

Nashville : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Nashville : Tennessee Oncology, Pllc

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Nashville : Vanderbilt University Medical Center/Clinical Trials Center

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Nashville : Sarah Cannon Research Institute

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Nashville : Henry-Joyce Cancer Clinic

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nashville : Tennessee Oncology, PLLC

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nashville : Sarah Cannon Cancer Center

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

Nashville : Sarah Cannon Research Institute

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Nashville : Vanderbilt Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplaston A10 And AS2-1 In Patients With Chronic Lymphocytic Leukemia

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Chronic Myelogenous Leukemia

View More »

Abilene : US Oncology - Texas Cancer Center - Abilene (South)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Amarillo : US Oncology - Texas Oncology, PA - Amarillo

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Amarillo : Texas Oncology

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Amarillo : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Arlington : US Oncology - Texas Oncology - Arlington South

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Arlington : Texas Oncology - Arlington South

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Austin : Texas Oncology-Austin North

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Beaumont : Julie & Ben Rogers Cancer Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Bedford : Texas Oncology-Bedford

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Bedford : US Oncology - Texas Oncology, PA - Bedford

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bryan : St. Joseph Regional Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

College Station : Scott & White Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Corpus Christi : South Texas Institute of Cancer

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Corpus Christi : Coastal Bend Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Corpus Christi : Driscoll Children'S Hospital

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Dallas : Mary Crowley Cancer Research Centers - Medical City Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Dallas : Baylor University Medical Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Dallas : UT Southwestern Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Dallas : Texas Oncology - Dallas Presbyterian Hospital

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Dallas : Texas Oncology - Medical City Dallas

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Dallas : US Oncology - Texas Oncology, PA - Dallas

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Dallas :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Dallas : University of Texas Southwestern Medical Center at Dallas

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Dallas : University of Texas Southwestern Medical Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Dallas : UT Southwestern Medical Center at Dallas

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Dallas : Texas Oncology, PA (North)

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

Dallas : Texas Oncology-Dallas Presbyterian Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Dallas : Texas Oncology-Methodist Charlton Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Dallas : Texas Oncology-Medical City Dallas

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

El Paso : US Oncology - El Paso Cancer Treatment Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

El Paso : US Oncology - El Paso Cancer Treatment Center - West

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fort Worth : Texas Oncology - Fort Worth 12th Avenue

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Fort Worth : Cook's Children's Medical Center

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Fort Worth : US Oncology - Southwest Fort Worth Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fort Worth : US Oncology - Texas Oncology, PA - Fort Worth

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fort Worth : JPS Center for Cancer Care

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Grapevine : US Oncology - Texas Oncology - Grapevine

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Houston : UT MD Anderson Cancer Center Updated

2CDA With Rituximab in Hairy Cell Leukemia

Houston : UT MD Anderson Cancer Center

4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies

Houston : UT MD Anderson Cancer Center

5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Houston : Md Anderson Cancer Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Houston : Texas Children'S Cancer Center

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Houston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study in Patients With Acute Leukemia

Houston : MD Anderson Cancer Center

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Houston :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Houston : MD Anderson Cancer Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Houston : MD Anderson Cancer Center

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Houston : M.D. Anderson Cancer Center

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Houston : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Houston : Site Reference ID/Investigator# 26522 Updated

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Houston : UT MD Anderson Cancer Center

Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin

Houston : MD Anderson Cancer Center

ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

Houston : Baylor College of Medicine

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Houston : M.D. Anderson Cancer Center

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Houston : MD Anderson Cancer and Research Center

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Houston : MD Anderson Cancer Center / University of Texas

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Houston : University of Texas MD Anderson Cancer Center

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)

Houston : MD Anderson Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Houston : Oncology Consultants

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Houston : The University Of Texas - M.D. Anderson Cancer Center

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Houston : The University of Texas MD Anderson Cancer Center

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

Houston : UT MD Anderson Cancer Center

Eltrombopag for Management of Thrombocytopenia

Houston : University of Texas MD Anderson Cancer Center

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Houston : The University Of Texas Md Anderson Cancer Center

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Houston : UT MD Anderson Cancer Center

Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies

Houston : UT MD Anderson Cancer Center

Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations

Houston : UT MD Anderson Cancer Center

Hyper CVAD Plus Ofatumumab in CD - 20 Positive Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

Hyper-CVAD and Ponatinib in Ph-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)

Houston : UT MD Anderson Cancer Center

Hyper-CVAD Plus Dasatinib in Philadelphia/BCR-ABL Positive ALL

Houston : UT MD Anderson Cancer Center

Inotuzumab Ozogamycin in Elderly Acute Lymphoblastic Leukemia (ALL)

Houston : M. D. Anderson Cancer Center at University of Texas

Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Houston : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Houston : UT MD Anderson Cancer Center

Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)

Houston : UT MD Anderson Cancer Center

Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)

Houston : U.T. M.D. Anderson Cancer Center

Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy

Houston : UT MD Anderson Cancer Center

Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Houston : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Houston : U.T.M.D. Anderson Cancer Center

Oral Clofarabine Study in Patients With Myelodysplastic Syndrome

Houston : UT MD Anderson Cancer Center

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

Houston : The University Of Texas - M.D. Anderson Cancer Center

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Houston : UT MD Anderson Cancer Center

Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients

Houston : The University of Texas MD Anderson Cancer Center

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Houston : UT MD Anderson Cancer Center

Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)

Houston : UT MD Anderson Cancer Center

Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)

Houston : The University of Texas M.D. Anderson Cancer Center

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Houston : UT MD Anderson Cancer Center

Phase II Study of Ofatumumab in Elderly Patients With Chronic Lymphocytic Leukemia (CLL)

Houston : UT MD Anderson Cancer Center

Phase l/II Study of Ruxolitinib for Acute Leukemia

Houston : UT MD Anderson Cancer Center

PKC412 and 5-Azacytidine

Houston : UT MD Anderson Cancer Center

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Houston : UT MD Anderson Cancer Center

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

Houston : MD Anderson Cancer Center

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Houston : UT MD Anderson Cancer Center

RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

Houston : University of Texas M. D. Anderson Cancer Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Houston : UT MD Anderson Cancer Center

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2

Houston : University of Texas/MD Anderson Cancer Center/Clinical Trials Center

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Houston : Novartis Investigative Site

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Houston : University of Texas M. D. Anderson Cancer Center

Safety and Efficacy of 72-hour and 120-hour Infusion of ON 01910.Na in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)

Houston : Research Site

Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients

Houston : UT MD Anderson Cancer Center

Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Houston : UT MD Anderson Cancer Center

Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)

Houston : Investigational Site Number 840001

SAR3419 in Acute Lymphoblastic Leukemia

Houston : UT MD Anderson Cancer Center Updated

Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome

Houston : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Houston : UT MD Anderson Cancer Center

Study of Dasatinib in Patients With Chronic Myelogenous Leukemia

Houston : University of Texas M.D. Anderson Cancer Center

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Houston : MD Anderson Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

Houston : MD Anderson Cancer Center

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Houston : Call for Information (Investigational Site 0002) Updated

Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)

Houston :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Houston : MD Anderson Cancer Center

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Houston : The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Houston : The University Of Texas Md Anderson Cancer Center

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Houston : MD Anderson Cancer

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Houston : Michael DeBakey VA Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Houston : University of Texas - MD Anderson Cancer Center

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Houston : MD Anderson Cancer Center

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

Houston : UT MD Anderson Cancer

Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Houston, : M.D. Anderson Cancer Center

Clinical Study of PM01183 in Patients With Acute Leukemia

Houston, Texas : The University of Texas, M.D. Anderson Cancer Center

A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL

Houton : MD Anderson

An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Kerrville : US Oncology - San Antonio Tumor & Blood Clinic - Kerrville

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lackland AFB : Wilford Hall Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lewisville : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Longview : US Oncology - Longview Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lubbock : Joe Arrington Cancer Research and Treatment Center Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Lubbock : Joe Arrington Cancer Research and Treatment Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

McAllen : US Oncology - Texas Oncology - McAllen

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

McAllen : Texas Oncology-McAllen South Second

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Mesquite : Texas Oncology- Mesquite

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Mesquite : US Oncology - Texas Oncology - Mesquite

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Mesquite : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Midland : US Oncology - Allison Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Midland : Texas Oncology-Midland Allison Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Odessa : Texas Oncology-Odessa West Texas Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Paris : US Oncology - Texas Oncology - Paris

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Paris : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Plano : North Texas Regional Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Round Rock : Texas Oncology - Central Austin Cancer Center

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

San Antonio : Cancer Centers of South Texas

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

San Antonio : Cancer Care Centers of South Texas

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

San Antonio : US Oncology - San Antonio Tumor & Blood Clinic - M. Oak

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

San Antonio : US Oncology - Cancer Care Centers of South Texas

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

San Antonio : University of Texas Health Science Center, San Antonio

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

San Antonio : Cancer Care Centers of South Texas

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

San Antonio : Cancer Therapy Reasearch Center at UTHSCA

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

San Antonio : Texas Transplant Physician's Group

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

San Antonio : Cancer Care Centers of South Texas

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

San Antonio : Cancer Care Centers of South Texas

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Sherman : US Oncology - Texas Oncology - Sherman

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Sugar Land : Texas Oncology - Sugar Land

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Temple : Scott & White Healthcare Department of Research

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Temple : Scott & White Healthcare

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Temple : Central Texas Veterans Health Care System

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Tyler : ETMC dba Blood and Cancer Center - East Texas

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Tyler : US Oncology - Texas Oncology - Tyler

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Tyler : ETMC dba Tyler Hematology Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Waco : US Oncology - Texas Oncology Cancer Care and Research Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Waco : Texas Oncology

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Weslaco : US Oncology - Texas Oncology - Weslaco

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Wichita Falls : US Oncology - Texoma Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

American Fork : Central Utah Clinic

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Logan : Cache Valley Cancer Treatment & Research Clinic, Inc.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Ogden : Northern Utah Associates

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Ogden : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Salt Lake City : University of Utah

A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

View More »

Salt Lake City : Huntsman Cancer Institute at the University of Utah Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Salt Lake City : University of Utah, Huntsman Cancer Institute

Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients

Salt Lake City :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Salt Lake City : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Salt Lake City : Huntsman Cancer Institute

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Abingdon : Cancer Outreach Associates, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Arlington : US Oncology - Arlington Fairfax Hematology Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Charlottesville : University of Virginia Health System Updated

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Christianburg : Oncology and Hematology Assoc of SW VA DBA Blue Ridge Cancer Care

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Christiansburg : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Christiansburg

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Fairfax : US Oncology - Fairfax Northern VA Hem-Onc PC

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Fredericksburg : Hematology Oncology Associates of Fredricksburg

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Gainesville : US Oncology - Fairfax - Northern Virginia Hematology-Oncology, PC - Gainesville

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Leesburg : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Leesburg

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Low Moor : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Low Moor

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Newport News : Peninsula Cancer Institute

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Norfolk : Virginia Oncology Associates

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

Richlands : Virginia Oncology Care, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Richmond : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Richmond : Massey Cancer Center/Virginia Commonwealth University

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

Roanoke : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Roanoke

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Roanoke : Blue Ridge Cancer Care

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Salem : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Salem

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Winchester : US Oncology - Shenandoah Oncology - Winchester

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Woodbridge : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Woodbridge

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Wytheville : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Wytheville

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Bellingham : Peace Health Medical Group

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Edmonds : Puget Sound Cancer Centers

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Edmonds : US Oncology - Puget Sound Cancer Center - Edmonds

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Everett : Providence Everett Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Kennewick : Columbia Basin Hematology and Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

View More »

Seattle : Site Reference ID/Investigator# 52882

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma

Seattle : Seattle Children'S

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Seattle : Seattle Cancer Care Alliance

A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)

Seattle : Fred Hutchinson Cancer Research Center

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Seattle :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Seattle :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Seattle : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Seattle : US Oncology - Puget Sound Cancer Center - Seattle

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Seattle :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Seattle : University Of Washington

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Seattle : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Seattle : Fred Hutchinson Cancer Research Center

Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Seattle : Fred Hutchinson Cancer Research Center

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Seattle : Seattle Cancer Care Alliance

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Seattle : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Seattle : Pfizer Investigational Site

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Seattle : Seattle Cancer Care Alliance

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Seattle :

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Seattle : Swedish Tumor Institute-Medical Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Seattle : Fred Hutchinson Cancer Research Center

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Seattle : Seattle Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Spokane : US Oncology - Cancer Care Northwest - Holland

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : US Oncology - Cancer Care Northwest - Sherman

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : Medical Oncology Associates PS

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : US Oncology - Cancer Care Northwest - Mission

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Spokane : Providence Cancer Center at Sacred Heart Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Spokane Valley : Cancer Care Northwest

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Tacoma :

A Study of GA101 (RO5072759) in Combination With Chemotherapy in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GALTON)

Vancouver : Northwest Cancer Specialist

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 136th St.

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 134th St

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Vancouver : Northwest Cancer Specialists - Vancouver Cancer Center

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

Walla Walla : Providence St. Mary Regional Cancer Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Walla Walla : Providence St. Mary Regional Cancer Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Wenatchee : Wenatchee Valley Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Wenatchee : Wenatchee Valley Medical Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Yakima :

A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Yakima : Yakima Valley Memorial Hospital / North Star Lodge

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Yakima : US Oncology - Yakima Valley Memorial Hospital/North Star Lodge (Boyd)

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Yakima : North Star Lodge Cancer Center

Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

E2906- Phase III trial of Clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed Acute Myeloid Leukemia in older adults (age greater than or equal to 60 years)

Morgantown : West Virginia University - Clinical Trials Research Unit

ECOG 10404: Randomizewd Ph2, Three Fludarabine/Antibody Combinations for patients with Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

S0535 - A Phase II Study of ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin in Patients with Previously Untreated, High-Risk Acute Promyelocytic Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

S0805 - Phase II Study of Combination of Hyper-CVAD and Dasatinib with or without allogeneic stem cell transplant in Patients with Philadelphia(Ph)Chromosome Postive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia(ALL)

View More »

Huntington : St. Mary's Medical Center

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Martinsburg : City Hospital - West Virginia University Hospital East

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Morgantown : Investigational Site Number 840002 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Morgantown : West Virginia University Hospital

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Morgantown : Department of Medicine Section of Hematology/Oncology, West Virginia University Hospitals, Mary Babb Randolph Cancer Center, West Virginia University

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Wheeling : Wheeling Hospital

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Green Bay : St. Vincent Hospital/Green Bay Oncology

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Green Bay : St Vincent Regional Cancer Center

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Green Bay : Bellin Memorial Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Janesville : Mercy Health System Heme/Onc

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

LaCrosse : Gundersen Clinic

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

View More »

Madison : Site Reference ID/Investigator# 56811

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma

Madison : Investigational Site

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Madison : University of Wisconsin

An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study

Madison : Kenneth DeSantes., MD

Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors

Madison : University of Wisconsin Carbone Cancer Center

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Madison : University of Wisconsin

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Marshfield : Marshfield Clinic

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Milwaukee : The Medical College of Wisconsin Updated

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Milwaukee : Medical College of Wisconsin

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Milwaukee : Medical College of Wisconsin

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Milwaukee : Froedtert Hospital, Medical College of Wisconsin

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Oconomowoc : Oconomowoc Memorial Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Waukesha : Waukesha Memorial Hospital

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Waukesha : Waukesha Memorial Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Wausau : Aspirus Regional Cancer Center

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Wisconsin Rapids : Riverview Hospital

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

Buenos Aires : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Buenos Aires : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Buenos Aires : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Buenos Aires : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Buenos Aires : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

View More »

Bunos Aires : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Capital Federal : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Ciudad Autonoma de Buenos Aires : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Ciudad Autonoma de Buenos Aires : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Cordoba : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Derqui, Pilar : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

El Palomar : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

La Plata : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Parana, Entre Rios : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Rio Negro : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Rosario : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

San Miguel De Tucuman : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Adelaide : IMVS Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Adelaide : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Adelaide : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Adelaide : Royal Adelaide Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Adelaide : IMVS

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

View More »

Adelaide : Flinders Medical Centre

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Adelaide : Royal Adelaide Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Adelaide : Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bedford Park : Flinders Medical Centre

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Camperdown : Royal Prince Alfred Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Clayton : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Concord : Concord Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Concord : Concord Repatriation General Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Darlinghurst : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Darlinghurst : St Vincent's Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

East Melbourne : Site Reference ID/Investigator# 48323

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma

East Melbourne : Peter MacCallum Cancer Centre

A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia

East Melbourne : Novartis Investigative Site

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

East Melbourne : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

East Melbourne : Peter MacCallum Cancer Centre

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Fitzroy : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Fitzroy : St. Vincent's Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Fitzroy : St. Vincent Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Fitzroy : St Vincent's Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Footscray : The Western Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Footscray : Western Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Frankston : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Frankston : Frankston Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Garran : The Canberra Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Geelong : Andrew Love Cancer Center, Geelong Hospital, Barwon Health

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Gosford : Haematology Department, Gosford Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Herston : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Herston : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Herston : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Herston, Brisbane : Royal Brisbane and Women's Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hobart : Investigational Site Number 036001 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Kingswood : Nepean Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Kingswood : Nepean Cancer Care Centre

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Melbourne : Alfred Hospital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Melbourne : Box Hill Hospital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Melbourne : Royal Melbourne Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Melbourne : Royal Melbourne Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Melbourne : The Alfred Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nedlands : Sir Charles Gairdner Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Nedlands : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

New Lambton Heights :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Newcastle : Calvary Mater Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

North Adelaide : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Northmead : Westmead Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Parkville : Site Reference ID/Investigator# 48322

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma

Parkville : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Parkville :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Parkville : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Parkville : Department of Clinical Haematology and BMT Service, Royal Melbourne Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Perth : Investigational Site Number 036003 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Perth : Sir Charles Gairdner Hospital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Prahran : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Prahran : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Prahran : The Alfred Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Randwick : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Randwick : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Randwick : Prince of Wales Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

St. Leonards : Royal North Shore Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

St. Leonards : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Sydney : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Sydney : Royal North Shore Hopsital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Waratah : Calvary Mater Newcastle

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Westmead : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Westmead :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Westmead : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Westmead : Westmead Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Westmead, NSW : Children's Hospital at Westmead

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Woolloongabba : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Woolloongabba : Princess Alexandra Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Feldkirch : LKH Feldkirch, Interne E

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Feldkirch : LKH Feldkirch, Interne E

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Graz : 1102 - LKH Graz

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Graz : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Graz : 1230.4.43001 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

View More »

Graz : Universitatsklinik Graz, Universitatsklinik fur Innere Medizin, Abteilung fur Hamatologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hall : A.ö. Bezirkskrankenhaus Hall in Tirol, Innere Medizin / Hämato - Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Innsbruck : Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Innsbruck : Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Innsbruck : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Innsbruck : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Innsbruck : Universitätsklinik Innsbruck, Innere MEdizin IV / Hämato-Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Innsbruck : Innsbruck Medical University

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Innsbruck : University Hospital for Internal Medicine V, Innsbruck Medical University

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Krems : Landesklinikum Krems, Hämato-onkologisches Service

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Kufstein : A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Leoben : A.ö. Landeskrankenhaus Leoben

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Linz : Krankenhaus der Stadt Linz

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Linz : AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinische Onkologie

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Linz : Krankenhaus d. Barmherzigen Schwestern Linz, Interne I

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Linz : Krankenhaus der Elisabethinen Linz GmbH, 1. Interne

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Linz : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Linz : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Linz : AKH Linz, Department für Innere Medizin 3

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Rankweil : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Salzburg : Universitaetsklinik f. Innere Medizin III

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Salzburg : Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Salzburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Salzburg : Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Salzburg : Landeskliniken Salzburg Saint Johanns-Spital, III Medizinische Abteilung

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Salzburg : Landeskrankenhaus Salzburg, Universitaetsklinik fur innere Medizin lll, Universitaetsklinikum der PMU

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Steyr : Landeskrankenhaus Steyr, Innere Medizin, Hämatologie, Onkologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Vienna : 1101 - AKH Wien

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Vienna : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Vienna : For additional information regarding sites for this trial call (919) 465-4648

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

Vienna : Medical University of Vienna

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Wels : Klinikum Wels-Grieskirchen GmbH

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Wels : Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Wels : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Wels : Klinikum Wels-Grieskirchen GmbH, Abteilung für Innere Medizin IV

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Wels : Klinikum Wels-Grieskirchen GmbH

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Wien : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Wien : Hanusch Krankenhaus, 3. Med. Abtlg. Für Hämatologie und Onkologie

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Wien : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Wien : Hanusch Krankenhaus, 3. Med. Abtlg.

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Wien : AKH Wien, Klinische Abteilung für Hämatologie und Hämostaseologie

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Wien : Wilhelminenspital, I Medizinische Abt.

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Wien : AKH Wien / MedUniWien Universtatsklinik fur Innere Medizin 1

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Minsk : Updated

A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-cell Chronic Lymphocytic Leukemia

Aalst : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Antwerp : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Antwerpen : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Antwerpen : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Antwerpen : ZNA Middleheim Lindendreef 1

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

View More »

Antwerpen : ZNA Stuivenberg, Lange Beeldekensstraat 267

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Brasschaat : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Brugge : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Brugge : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Brugge : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Brugge : Algemeen Ziekenhuis Sint-Jan

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Brugge : Algemeen Ziekenhuis Sint-Jan

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Brugge : AZ St.-Jan Brugge-Oostende AV

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Brussels : 1502 - Cliniques Universitaires de Saint-Luc

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Brussels : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Brussels : UZ Brussel

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Brussels : Institut Jules Bordet

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Brussels : CHU Erasme Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Brussels : Cliniques Universitaires Saint Luc

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bruxelles : Investigational Site Number 056003 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Bruxelles : Hopital Des Enfants Reine Fabiola

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bruxelles : Hopital Saint Luc

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bruxelles : 1270.1.32001 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Bruxelles : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Bruxelles : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bruxelles : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Bruxelles : Institut Jules Bordet

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Charleroi : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Charleroi : Grand Hôpital de Charleroi

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Edegem : University Hospital Antwerp

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Gent : Investigational Site Number 056002 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Gent : UZ Gent Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Gent : 1270.1.32003 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Gent : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Gent : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Gent : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Gent : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Gent : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Ghent : Universitair Ziekenhuis Gent

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Godinne : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Godinne : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Haine Saint Paul : Hopital de Jolimont

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Haine-Saint Paul : Hopital de Jolimont Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Haine-Saint-Paul : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hasselt : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hasselt : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Jette : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Kortrijk : AZ Groeninge Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Kortrijk : AZ Groeninge Kortrijk

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

La Louvière : Centre Hospitalier de Jolimont-Lobbes

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Laeken : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Leuven : Investigational Site Number 056001 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Leuven : 1270.1.32002 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Leuven : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Leuven : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Leuven : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Leuven : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Leuven : UZ Leuven

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Leuven : UZ Leuven, campus Gasthuisberg, Department of Haematology

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Liege : Chr de La Citadelle

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Liege : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Liège : CHU Liège

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Luxembourg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Montegnee : Chc Esperance

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Montigny-Le Tilleul : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Roeselare : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Roeselare : H.-Hartziekenhuis Roeselare - Menen vzw

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Yvoir : 1501 - Cliniques Universitaires UCL de Mont Godinne

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Yvoir : UCL Mont-Godinne

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Yvoir : Clinique Universitaire de Mont Godinne

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Yvoir : Cliniques Universitaires UCL de Mont-Godinne

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Belo Horizonte : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Botucatu : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Brasilia : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Campinas : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Campinas : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

View More »

Cuiaba : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Curitiba : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Curitiba : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Florianopolis : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Fortaleza : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Jaú : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Londrina : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Porto Alegre : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Porto Alegre : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Rio de Janeiro : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Rio de Janeiro : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Sao Paulo : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

São Paulo : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

São Paulo : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Pleven : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Pleven : Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Plovdiv : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Plovdiv : Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Sofia : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

View More »

Sofia : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Sofia : Military Medical Academy Clinic of Hematology and Oncology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Varna : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Varna : UMHAT Clinic of Hematology

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Barrie : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Brampton : William Osler Health System - Brampton Civic Hos

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Brampton : CA009

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Calgary : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Calgary : CA015

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

View More »

Calgary :

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Calgary : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Calgary : Tom Baker Cancer Centre

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Calgary : Alberta Children's Hospital

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Edmonton : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Edmonton :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Edmonton : CA014

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Edmonton : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Edmonton : Cross Cancer Institute University of Alberta

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Edmonton : University of Alberta Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Greenfield Park : Hopital Charles LeMoyne

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Greenfield Park : Charles LeMoyne Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Halifax : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Halifax : CDHA Centre for Clinical Research Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Halifax : CA004

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Halifax : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Halifax : Queen Elizabeth II Health Sciences Centre

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Halifax : Queen Elizabeth II Health Sciences Centre

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hamilton : CA003

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Hamilton : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Hamilton : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Hamilton : Juravinski Cancer Centre

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Kelowna : CA016

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Kitchener : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Montreal : Updated

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Montreal : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Montreal :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Montreal : Hopital Maisonneuve Rosemont Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Montreal : Royal Victoria Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Montreal : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Montreal : Mc Gill University Department of Oncology

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Montreal : Hospital Maisonneuve-Rosemont

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Montreal : CA001

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Montreal : CA010

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Montreal : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Montreal : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Montreal : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Montreal : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Montreal : 1230.4.1002 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Montreal : Hopital du Sacre-Coeur de Montreal

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Montreal : Centre Hospitalier de l'Université de Montréal pavilion Notre Dame

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Montreal : Hopital du Sacre Coeur de Montréal

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Montreal : Hopital Maisonneuve-Rosemont

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Ontario : Princess Margaret Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Ottawa : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Ottawa : CA002

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Ottawa : Ottawa Hospital General Campus

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Quebec : Hopital de L'Enfant-Jesus Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Quebec : CA008

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Québec : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Rimouski : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Saint John : Atlantic Health Sciences Corporation Saint John Regional Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Saint John : Saint John Regional Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Sherbrooke : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Sherbrooke : 1230.4.1003 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

St. John : Atlantic Health Sciences Corporation, Saint John Regional Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

St. Johns : Health Sciences Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

St. Johns : Health Sciences Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Toronto : Updated

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Toronto : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Toronto : Princess Margaret Hospital

A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Toronto : Princess Margaret Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Toronto : Princess Margaret Hospital

An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment

Toronto : University Health Network-Princess Margaret Hospital

An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)

Toronto : Princess Margaret Hospital

Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Toronto : CA006

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Toronto : Research Site

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Toronto : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Toronto : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Toronto : University Health Network, Princess Margaret Hospital

Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients

Toronto : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Toronto : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Toronto : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Toronto : University Health Network - Princess Margaret Hospital

Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia

Toronto : 1230.4.1001 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Toronto : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Toronto : Princess Margaret Hospital

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia

Toronto : Research Site

Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients

Toronto : Princess Margaret Hospital

Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Toronto : Princess Margaret Hospital

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Toronto : Sunnybrook Odette Cancer Centre

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Toronto : University Health Network, Princess Margaret Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Toronto : Hospital for Sick Kids

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Vancouver : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Vancouver : Leukemia BMT program of BC, Vancouver General Hospital, Hematology Research and Clinical Trials Unit

A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib

Vancouver :

A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Vancouver : CA011

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Vancouver : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Vancouver : Division of Hematology, Vancouver General Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Victoria : CA013

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Windsor : CA005

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Winnipeg : Cancer Care Manitoba

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Renaca : Instituto Oncologico Anabaena 336 Vina del Mar V Region

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Temuco : Instituto Clinico Oncologico del Sur (ICOS) Lago Puyehue 01745 Temuco IX Region de La Araucania

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Beijing : Beijing Clinical Service Center

Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia

Beijing : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Beijing : Peking Union Medical College Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Beijing : The Third Hospital of Peking University

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Chengdu : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

View More »

Fuzhou : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Fuzhou : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Guangzhou : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Hangzhou : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Hong Kong : Department of Paediatrics and Adolescent Medicine, The University of Hong Kong

A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma

Jiangsu : Peoples Hospital of Jiangsu Province

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Jinan : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Nan Jing : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Nanjing : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Shanghai : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Shanghai : Shanghai Changhai Hospital,the Second Military Medical University

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Shanghai : Shanghai Ruijin Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Shanghai : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Sichuan : West China Hospital,Sichuan University

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Tianjin : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Tianjin : Tianjin Blood Disease Hospital

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Tianjin : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Wuhan : Novartis Investigative Site

Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients

Bogota : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Monteria : Oncomedica S.A

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Monteria : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Zagreb : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Zagreb : University Hospital Dubrava

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Brno : Lekarna fakultni nemocnice V Brne Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Brno : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Brno : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Brno : FN Brno

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Brno : University Hospital Brno

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

View More »

Brno : Fakultni nemocnice Brno

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Brno : Fakultni nemocnice Brno, Interni hematoonkologicka klinika

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Brno - Bohunice : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hradec Kralove : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hradec Kralove : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Hradec Kralove : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Hradec Kralove : FN Hradec Kralove

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Hradec Kralove : Faculty Hospital Hradec Kralove

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Hradec Kralove : Fakultni nemocnice Hradec Kralove, 2. Interni klinika-oddeleni klinicke hematologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Novy Jicin : Oncology Centre J.G. Mendela Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Olomouc : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Olomouc : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Olomouc : FN Olomouc

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Olomouc : Fakultni nemocnice Olomouc, hemato-onkologicka klinika

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Ostrava : Fakultni nemocnice Ostrava

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Plzen : Faculty Hospital Plzen Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Prague : General Faculty Hospital 1 - Internal Clinic Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Praha : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Praha : VFN Praha 2

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Praha : FN Kralovske Vinohrady

Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

Praha : Ustavni lekarna Fakultni nemocnice Kralovske Vinoh

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Praha : Fakultni nemocnice Kralovske Vinohrady, Oddeleni klinicke hematologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Praha 2 : Ustav hematologie a krevni transfuze

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Praha 2 : Vseobecna Fakultni Nemocnice v Praze

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Aalborg : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Århus : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Copenhagen : Rigshospitalet University Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Copenhagen : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Copenhagen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

View More »

Copenhagen : Copenhagen University Hospital Rigshospital

Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)

Copenhagen : Rigshospitalet University Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Herlev : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Herlev : Herlev Hospital

Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)

Herlev : Copenhagen University Hospital at Herlev

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Koebenhavn Oe : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Odense C : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Vejle : Vejle Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Vejle : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Cairo : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Cairo : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Tallinn : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Helsinki : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Helsinki : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

HUS Helsinki : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Oulu : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

OYS : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

View More »

Pori : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Tampere : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Turku : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Vantaa : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Aix En Provence : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Albi : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Amiens : Hopital Nord

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Amiens : Groupe Hospitalier Sud

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Amiens : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

View More »

Amiens : CHU Amiens

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Amiens Cedex 1 : Centre Hospitalier Universitaire d'Amiens, Groupe Hospitalier Sud

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Angers : Chu D'Angers

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Angers : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Angers : 1211 - CHU d'Angers

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Angers : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Angers : CHRU Angers

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Angers : Mathilde HUNAULT BERGER

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

Angers : CHU Angers Service de Medecine D - Maladies du Sang

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Angers Cedex 01 : CHU Angers, Service des maladies du sang

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Angers cedex 09 : CHRU d'Angers

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Aquitaine : Centre Hospitalier de la Cote Basque

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Argenteuil : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Argenteuil : Hopital Victor Dupouy

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Argenteuil : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Avignon : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Avignon : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Avignon : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Avignon : CHU Avignon Centre Hospitalier Henri Dufaut

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Bayonne : Ch de La Cote Basque

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bayonne cedex : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Besancon : Hopital Jean Minjoz

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Besancon : Hopital Saint Jacques

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Besancon : (CHU Besancon) Hopital Saint-Jaques

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Besancon : CHU Hôpital Minjoz

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Besancon : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Beziers : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Blois : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Blois : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Blois cedex : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Bobigny : Hopital Avicenne

A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Bobigny : Hôpital Avicenne Hématologie Clinique

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Bobigny : Hopital Avicenne

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Bobigny : Hospital Avicenne, Service d'hematologie Clinique

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Bobigny : Hopital Avicenne- Departement Onco-hematologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Bobigny Cedex : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Bobigny Cedex : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Bordeaux : Updated

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Bordeaux : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Bordeaux : Hopital Pellegrin Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Bordeaux : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Bordeaux : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Bordeaux : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Bordeaux : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Bordeaux : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Bordeaux : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Bordeaux : Service d'hémato-oncologie - Hôpital des Enfants Pellegrin

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Bordeaux cedex : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Bourg En Bresse : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Brest : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Brest : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Brest : CHU Morvan

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Brest : Hôpital Morvan

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Caen : Chu Cote de Nacre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Caen : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Caen : CHU Caen Hématologie Clinique

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Carcassonne : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Cergy Pontoise : 1206 - Hôpital de Pontoise

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Chalon Sur Saone : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Chambery : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Clamart Cedex : Hopital Percy Clamart

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Clermont Ferrand : Chu Estaing

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Clermont Ferrand : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Clermont-ferrand : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Clermont-Ferrand : CHU Hôtel Dieu

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Clermont-Ferrand : CHU Estaing Service d'hématologie

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Clermont-Ferrand : CHU de Clermont-Ferrand

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Clermont-Ferrand : Hémato-Oncologie et Thérapie Cellulaire Pédiatrique - Hôtel Dieu

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Colmar : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Colmar : CH Louis Pasteur

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Creteil : Hopital Henri Mondor

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Creteil : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Creteil : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Créteil : 1205 - CHU Henri Mondor

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Dijon : Hopital Du Bocage

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Dijon : CHU du Bocage

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Dijon : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Dijon : Dijon hôpital d'enfants

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Dijon : Hémato-Oncologie Pédiatrique - Hôpital d'Enfants

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Dunkerque : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Grenoble : Chu Grenoble

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Grenoble : CHU Michallon

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Grenoble : Hôpital Michallon

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Grenoble : Hopital A Michalon

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Grenoble Cedex 09 : CHU de Grenoble

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Grenoble cedex 9 : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

La Roche Sur Yon : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

La Roche sur Yon : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

La Tronche : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Le Chesnay : Ch de Versailles - Hopital Mignot

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Le Chesnay : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Le Chesnay : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Le Chesnay : Hopital Mignot

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Le Coudray : Nfovartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Le Mans : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Le Mans : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Le Mans : Centre Jean-Bernard - Clinique Victor Hugo

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Lille : Chru Lille

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Lille : Chru Lille - Hop Jeanne de Flandres

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Lille : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Lille : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Lille : CHU Lille Hôpital Claude Huriez

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Lille : Hôpital Jeanne de Flandre

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Lille : CHU Lille, Service des maladies du sang, Hopital Huriez

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Lille cedex : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Lille Cedex : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Lille cedex : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Limoges : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Limoges : Chu Dupuytren

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Limoges : CHU Dupuytren

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Limoges : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Limoges : CHU Limoges Hopital Dupuytren

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Limoges : Limoges University Hospital

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Limoges : Centre Hopitalier Universitaire Dupuytren

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Lyon : Updated

A First-In-Human Study of RO5503781 in Patients With Advanced Malignancies, Except Leukemia

Lyon : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Lyon : CHU Lyon, Hospital Edouard Herriot

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Lyon : Institut Hematologie Oncologie Pediatrique

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Lyon : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Lyon : Hôpital Edouard Herriot

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Lyon : Xavier THOMAS

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia

Lyon Cedex : Hospital Edouard Herriot, Service d'Hematologie Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Lyon Cedex 03 : Centre Hospitalier Universitaire de Lyon-Hôpital Edouard Herriot

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Lyon Cedex 08 : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Mâcon : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Marseille : Institut Paoli-Calmettes

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Marseille : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Marseille : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Marseille : Chu Timone Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Marseille : Institut Paoli Calmettes

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Marseille : Institut Paoli Calmette

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Marseille : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Marseille : Institut Paoli Calmettes

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Marseille : Hôpital de la Conception

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Marseille : Institut Paoli Calmettes

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Marseille Cedex 09 : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Marseille cedex 9 : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Marseille Cedex 9 : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Marseille Cedex 9 : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Marseille Cedex 9 : Local Institution

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Meaux : Centre Hospitalier de Meaux

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Metz : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Metz : CH Metz Thionvile

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Metz Tessy : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Montauban : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Montpellier : Investigational Site Number 250002 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Montpellier : Hopital Saint Eloi

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Montpellier : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Montpellier : CHU Lapeyronie

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Montpellier : Guillaume CARTRON

Intensified Rituimab Prephase Before FCR in Untreated B-CLL

Montpellier : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Montpellier Cedex 05 : Hôpital Lapeyronie

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Montpellier Cedex 5 : 1270.1.33001 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Mulhouse : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Mulhouse : Hopital Emile Muller

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Mulhouse : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Mulhouse : CH Muller

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Mulhouse : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Mulhouse : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Mulhouse : Centre Hospitalier de Mulhouse - Hopital Emile Muller

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Nancy : CHU Brabois

A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Nantes : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Nantes : Hopital Mere Enfant

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Nantes : Hotel Dieu

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Nantes : 1212 - Hôpital de l'hôtel Dieu

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Nantes : CHU Hôtel Dieu

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Nantes : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Nantes : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Nantes : CHU Nantes Hotel Dieu, Service d'hematologie clinique

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nantes : Hospital Hotel Dieu, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Nantes Cedex : CHU Hotel Dieu Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Nantes cedex 1 : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Nantes Cedex 1 : Centre Hospitalier Universitaire Nantes, Hotel Dieu

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Nice : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Nice : Hopital de l'Archet 1 Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Nice : Hopital de L'Archet 2

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Nice : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Nice : Hopital de l'Archet

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Nice Cedex 3 : Centre Hospitalier Universitaire de Nice

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Nimes : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Nimes : CHU Carémeau

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Nîmes : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Orléans : CH La Source

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Paris : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Paris : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Paris : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Paris : Hopital Saint Louis

A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q

Paris : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Paris : Hopital Armand Trousseau

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Robert Debre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Hotel Dieu

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Saint Louis

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Necker Enfants Malades

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Hopital Saint Antoine

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Paris : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Paris : 1201 - Hôpital Saint Louis

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Paris : Hopital Cochin (AP-HP)

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Paris : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Paris : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Paris : Hôtel Dieu Sce Hématologie Clinique

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Paris : Hématologie Pédiatrique - Hôpital Trousseau

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Paris : Hôpital Pitié Salpétrière

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Paris : Children Armand Trousseau Hospital

Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2

Paris : Hospital Saint Louis, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Paris Cedex 10 : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Paris Cedex 10 : Hôpital Saint Louis

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Paris Cedex 10 : Local Institution

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Paris Cedex 12 : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Paris cedex 12 : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Paris cedex 15 : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Paris Cedex 19 : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Perpignan : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Perpignan : Ch de Perpignan

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Perpignan : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Perpignan : CHU Perpignan Centre Hospitalier Hôpital Saint-Jean

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Perpignan : CH Perpignan - Hopital Saint-Jean

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Pessac : Hopital Haut-Leveque

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Pessac : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Pessac : 1202 - CHU de Bordeaux - Hôpital Haut Lévêque

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Pessac : CHU du Haut Lévèque

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Pessac : CHU Haut-Leveque

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Pessac : CHU de Bordeaux- Hopital Haut-Leveque, Centre Francois Magendle

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Pessac : CHU du Haut-Leveque, Service des Matadies du Sang Unite de Recherche Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Pessac cedex : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Pierre Benite : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Pierre Benite : Hopital Lyon Sud

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Pierre Benite : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Pierre Benite : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Pierre Benite : Centre Hospitalier Lyon Sud - Service d'Hematologie - Pavillon Marcel Berard - Bat. 1G - 1er etage, 165 Chemin du grand Revoyet

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Pierre Bénite : Centre Hospitalier Lyon sud

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Pierre Benite Cedex : Investigational Site Number 250001 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Pierre Benite Cedex : CHU Lyon Sud Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Poitiers : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Poitiers : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Poitiers : CHU La Miletrie Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Poitiers : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Poitiers : CHU Jean Bernard - La Milétrie

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Poitiers : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Poitiers : University Hospital

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

Poitiers : University Hospital

STI571 ProspectIve RandomIzed Trial: SPIRIT

Poitiers Cedex : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Pontoise : Centre Hospitalier Rene Dubos

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Pontoise : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Pringy : Ch de La Region D'Annecy

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Pringy cedex : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Reims : Hopital Robert Debre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Reims : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Reims : CHU Robert Debré

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Reims : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Reims Cedex : Hôpital Robert Debré, CHU de Reims

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Rennes : Investigational Site Number 250004 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Rennes : Hopital de Pontchaillou

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Rennes : Chru Hopital Sud

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Rennes : CHU Pontchaillou

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Rennes Cedex : CHU de Rennes Hôpital de Pontchaillou

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Roubaix : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Rouen : CLCC H Becquerel Hematology Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Rouen : Centre Henri Becquerel

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Rouen : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Rouen : Stephane LEPRETRE

Intensified Rituimab Prephase Before FCR in Untreated B-CLL

Rouen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Rouen : CRLCC Henri Becquerel

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Rouen : Service d'Immuno Hémato Oncologie Pédiatrique - Hôpital Charles Nicolle

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Rouen Cedex : Investigational Site Number 250005 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Saint Etienne : Chu Hopital Nord

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Saint Etienne : Institut de Cancérologie de la Loire

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Saint Priest En Jarez : Institut Cancerologie de La Loire

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Saint Priest en Jarez : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Saint Priest en Jarez Cedex : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Salouel : Updated

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)

Salouel : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

St Brieuc : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

St Priest en Jarez : Institut de Cancerologie de la Loire

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

St Quentin : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Strasbourg : Hopital de Hautepierre

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Strasbourg : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Strasbourg : CHU Hautepierre

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Strasbourg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Strasbourg : CHU Hautepierre

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Strasbourg : Centre Hospitalier Régional Universitaire, Hôpital de Hautepierre

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Strasbourg Cedex : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Toulon : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Toulouse : CHU Toulouse, Hospital Purpan

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Toulouse : Hopital de Purpan

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Toulouse : Chu de Toulouse Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Toulouse : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Toulouse : CHU Purpan

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Toulouse : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Toulouse : Hôpital Purpan

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Toulouse : Service d'hematologie- Hopital Purpan- CHU de Toulouse

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Toulouse Cedex 09 : Local Institution

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Toulouse Cedex 09 : Centre Hospitalier Universitaire de Toulouse

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Toulouse Cedex 9 : 1270.1.33003 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Toulouse cedex 9 : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Tours : Hopital Bretonneau

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Tours : CHU Bretonneau

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Tours Cedex : Hopital Bretonneau Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Troyes : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Troyes : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Valence : Updated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia

Valenciennes : Hotel Dieu

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Vandoeuvre cedex : CHRU - Hôpital de Brabois

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Vandoeuvre Les Nancy : Hopital de Brabois

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Vandoeuvre Les Nancy : Hopital Brabois Enfants

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Patients (Adults/Children) With Relapse of Acute Lymphoblastic Leukemia

Vandoeuvre Les Nancy : CHU Brabois

Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

Vandoeuvre les Nancy : Novartis Investigative Site

Nilotinib Versus Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Pts With Evidence of Persistent Leukemia by RQ-PCR (ENESTcmr)

Vandoeuvre Les Nancy : Hôpital d'enfants

Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children

Vandoeuvre-les-nancy : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Vandoeuvre-Les-Nancy : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Villejuif Cedex : Investigational Site Number 250003 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Aachen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Aschaffenburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Aschaffenburg : Local Institution

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Augsburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Baden-Baden : Local Institution

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

View More »

Bamberg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bayreuth : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Berlin : Charite University Hospital Benjamin Franklin

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Berlin : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Berlin : Charité, Campus Benjamin Franklin Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Berlin : Charité - Campus Benjamin Franklin

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Berlin : Charité Campus Virchow Klinikum, Otto-Heubner-Centrum (OHC) für Kinder- und Jugendmedizin

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Berlin : 1011 - Charité Berlin

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Berlin : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Berlin : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Berlin : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Berlin : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Berlin : 1230.4.49006 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Berlin : Charité-Campus B. Franklin Med. Klinik Haematology

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Berlin : Charite Campus Benjamin Franklin

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Berlin : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Berlin : Novartis Investigative Site

To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib

Berlin : Charité Campus Benjamin Franklin Hämatologie, Onkologie, Transfusionsmedizin Medizinische Klinik III

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Berlin : Charité University Hospital Campus Virchow

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Bielefeld : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bonn : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bonn : Evangelische Kliniken Johanniter- und Waldkrankenhaus Bonn GmbH

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Bottrop : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bremen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bremen : Prof. Hess Childrens's Hospital, Pediatric Oncology and Hematology

Vorinostat in Children

Chemnitz : Klinikum Chemnitz gGmbH

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Cologne : University Hospital of Cologne

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomid in Patients With Chronic Lymphocytic Leukemia

Cologne : University Hospital Cologne

Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)

Cottbus : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Detmold : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Donauwoerth : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Dresden : University Hospital Carl Gustav Carus

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Dresden : Medizinische Klinik und Poliklinik I, Uniklinik

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes

Dresden : 1022 - Universitätsklinkum Carl Gustav Carus Dresden

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Dresden : Dresden University of Technology, Medizinische Klinik und Poliklinik 1

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Dresden : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Dresden : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Dresden : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Dresden : Novartis Investigative Site

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Dresden : Klinikum Carl Gustav Carus der Technischen Universität

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Duesseldorf : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Duesseldorf : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Düesseldorf : Heinrich-Heine-Universität Düsseldorf

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Duisburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Duisburg : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Duisburg : St. Johannes-Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Duisburg : St. Johannes-Hospital

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Düsseldorf : Universitätsklinikum Düsseldorf

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Düsseldorf : Universitätsklinikum Düsseldorf, Klinik für Hämatologie/Onkologie/klinische Immunologie

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes

Düsseldorf : University Hospital

Dose-reduced Versus Standard Conditioning in MDS/sAML

Düsseldorf : University Hospital Düsseldorf

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Düsseldorf : Heinrich-Heine Universität Düsseldorf, Klinik für Hämatologie/Onkolog. und Klin. Immunologie

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Eisenach : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Erlangen : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Erlangen : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Erlangen : Universität Erlangen-Nürnberg Med. Klinik V/Hämatologie

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Eschweiler : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Essen : Universitaetsklinikum Essen Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Essen : 1009 - Universitätsklinikum Essen

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Essen : Klinikum Essen-Werden

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML

Essen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Essen : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Essen : Universitaetsklinikum Essen

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Essen : Universitatsklinikum Essen, Zentrum fur Tumorforschung und Tumortherapie

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Essen : Universitätsklinikum Essen Westdeutsches Tumorzentrum

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Frankfurt : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Frankfurt : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Frankfurt : Klinikum der Goethe Universität, Medizinische Klinik II

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Frankfurt : Klinikum der J.W. Goethe-Universität, Medizinische Klink II

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes

Frankfurt : 1002 - Klinikum der Goethe Universität

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Frankfurt : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Frankfurt : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Frankfurt : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Frankfurt : Novartis Investigative Site

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Frankfurt : Klinikum Frankfurt am Main-Hochst, Department of Hematology and Oncology, Klinikum Frankfurt Academic Hospital of the University of Frankfurt

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Frankfurt : Universitätsklinikum Frankfurt Medizinische Klinik II

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Frankfurt / Oder : Innere Medizin Klinikum Frankfurt/Oder GmBH Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Frankfurt Am Main : Investigational Site Number 276003 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Frankfurt am Main : Local Institution

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Frankfurt An Der Oder : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Frankfurt/M : Novartis Investigative Site

To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib

Frankfurt/Main : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Frankfurt/Main : 1230.4.49003 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Frankfurt/Main : Local Institution

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Freiburg : Novartis Investigative Site

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Freiburg : University Hospital Freiburg Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Freiburg : Universitätsklinikum Freiburg

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Freiburg : Universitätsklinikum Freiburg

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML

Freiburg : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Freiburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Freiburg : 1230.4.49005 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Fulda : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Garmisch-Partenkirchen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Gerlingen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Germering : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Giessen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Goettingen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Goslar : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Gottingen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Göttingen : Universitätsmedizin Göttingen Hämatologie / Onkologie

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Greifswald : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Greifswald : Ernst-Moritz-Arndt-Universitaet Greifswald

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Groitzsch : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Gutersloh : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hagen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hagen : Katholisches Krankenhaus Hagen gGmbH Klinik für Hämatologie und Onkologie

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Halberstadt : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Halle : Martin-Luther-Universität Halle-Wittenberg

Dose-reduced Versus Standard Conditioning in MDS/sAML

Halle : Martin-Luther-Universität Halle-Wittenberg

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Halle : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hamburg : 1014 - Asklepiosklinik St. Georg

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Hamburg : University Hospital Eppendorf

Dose-reduced Versus Standard Conditioning in MDS/sAML

Hamburg : University Medical Center Hamburg-Eppendorf

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Hamburg : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Hamburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hamburg : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Hamburg : 1230.4.49008 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Hamburg : Universitatsklinikum Hamburg-Eppendorf; ll. Medizinische Klinik und Poliklinik; Onkologie, Hamatologie und Knochenmarktransplantation

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hamburg : Asklepios Klinik St. Georg Hämatologie & Stammzelltransplantation

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Hamburg : Asklepios Klinik Altona II. Medizinische Abteilung

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Hamm : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hamm : Evangelisches Krankenhaus Medizinische Klinik Hämatologie/Onkologie

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Hannover : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Hannover : Hannover Medical School

ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

Hannover : Medizinische Hochschule Hannover

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Hannover : 1018 - Medizinische Hochschule Hannover

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Hannover : Hannover Medical School

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML

Hannover : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hannover : Novartis Investigative Site

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Hannover : Medizinische Hochschule Hannover, Abteilung Hamatologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Hannover : Medizinische Hochschule Hannover

TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia

Hannover : Medical University Hannover

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Heidelberg : 1270.1.49003 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Heidelberg : 1012 - Universitätsklinikum Heidelberg

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Heidelberg : University Hospital

Dose-reduced Versus Standard Conditioning in MDS/sAML

Heidelberg : University Hospital Heidelberg

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Heidelberg : 1230.4.49004 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Heidelberg : Universitatsklinikum Heidelberg

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Heidelberg : Universitätsklinikum Heidelberg

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Heidelberg : Clinic for Pediatric Oncology, Hematology, Immunology and Clinical Cooperation Unit Pediatric Oncology

Vorinostat in Children

Heilbronn : SLK-Kliniken Heilbronn GmbH, Medizinische Klinik

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Herrsching : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Hildesheim : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Homburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Jena : Investigational Site Number 276002 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Jena : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Jena : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Jena : Universitätsklinikum Jena

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Jena : Novartis Investigative Site

To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib

Jena : University Childrens's Hospital, Pediatric Oncology and Hematology

Vorinostat in Children

Karlsruhe : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Karlsruhe : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Kassel : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Kempten : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Kiel : Universitätsklinikum Schleswig-Holstein

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Kiel : 1003 - Universitätsklinikum Schleswig-Holstein

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Kiel : UKSH Campus Kiel

Dose-reduced Versus Standard Conditioning in MDS/sAML

Kiel : UKSH Campus Kiel

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Kiel : 1230.4.49007 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Kiel : University of Schleswig Holstein

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Kiel : Staedtisches Krankenhaus Kiel GmbH, Infektionsambulanz der 2. Medizinischen Klinik

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Kiel : Universitätsklinikum Schleswig-Holstein

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Koblenz : Practice for Hematology and Oncology Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Koblenz : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Koblenz : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Koeln : Universitatetsklinik Koeln Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Koeln : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Koeln : Klinikum der Universität zu Koeln

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Köln : 1270.1.49002 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Köln : University Hospital

Dose-reduced Versus Standard Conditioning in MDS/sAML

Köln : University Hospital Köln

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Köln : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Köln : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Köln : University Children's Hospital, Pediatric Oncology and Hematology

Vorinostat in Children

Kronach : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Landshut : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Leipzig : University Hospital Leipzig Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Leipzig : 1019 - Universitätsklinikum Leipzig

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Leipzig : Novartis Investigative Site

Determining the Maximum Tolerated Dose of Low Dose Interferon-alfa in Conjunction With Nilotinib in Imatinib Resistant and/or Intolerant Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)

Leipzig : University Hospital

Dose-reduced Versus Standard Conditioning in MDS/sAML

Leipzig : University Hospital Leipzig

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Leipzig : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Leipzig : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Leipzig : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Leipzig : Universitätsklinikum Leipzig

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Leipzig : Klinikum St. Georg gGmbH; Klinik fur Internistische Onkologie/Hamatologie

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Leipzig : Universität Leipzig José-Carreras-Haus Abt. Hämatologie / Onkologie

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Lemgo : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Leverkusen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Lorrach : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Lubeck : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Luebeck : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Mainz : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Mainz : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Mainz : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Mainz : III. Medizinische Klinik und Poliklinik;Hämatologie, Onkologie und Pneumologie

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Mainz : Universitätsmedizin Mainz III. Medizinische Klinik

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Mannheim : Mannheimer Onkologie Praxis Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Mannheim : Novartis Investigative Site

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Mannheim : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Mannheim : Novartis Investigative Site

To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib

Marburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Moers : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Mönchengladbach : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Muenchen : TU Muenchen - Klinikum rechts der Isar Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Muenchen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Muenster : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Muenster : GSK Investigational Site

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Muenster : University Hospital of Muenster

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Muhlheim : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

München : Klinikum der Universität München, Dr. von Haunersches Kinderspital

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

München : Technische Universität München, Klinikum Rechts der Isar

Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes

München : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

München : Klinikum Rechts der Isar der TU München III. Medizinische Klinik

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Munich : 1010 - Klinikum der Universität München - Großhadern

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Munich : Klinikum rechts der Isar der Technischen Universitat Munchen lll, Medizinische Klinik

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Munster : Universitätsklinikum Munster

Dose-reduced Versus Standard Conditioning in MDS/sAML

Münster : Universitätsklinikum Münster

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Münster : Universitätsklinikum Münster

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Münster : 1004 - Universitätsklinikum Münster

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Münster : Universitätsklinikum Münster

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Münster : Universitätsklinikum Münster, Medizinische Klinik und Poliklinik A

Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)

Münster : 1230.4.49002 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Münster : Universitätsklinikum Münster, Medisinische Klinik & Poliklinik A

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Münster : Universitätsklinikum Münster

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Mutlangen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Neunkirchen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Nuernberg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Nürnberg : Klinikum Nürnberg Nord

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nürnberg : Klinikum Nürnberg, 5. Medizinische Klinik

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Offenbach : Local Institution

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting

Offenburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Oldenburg : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Oldenburg : Klinikum Oldenburg Innere Medizin II

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Paderborn : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Passau : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Pinneberg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Pluderhausen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Ravensburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Regensburg : 1016 - Universitätsklinikum Regensburg

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Regensburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Regensburg : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Regensburg : Klinikum der Universität Regensburg

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Rostock : 1020 - Universitätsklinikum Rostock

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Rostock : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Rostock : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Rostock : Universitätsklinikum Rostock

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Rostock : University of Rostock, Div. of Haematology and Oncology

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Rotenburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Schwäbisch-Hall : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Sindelfingen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Stuttgart : 1007 - Robert-Bosch-Krankenhaus

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Stuttgart : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Stuttgart : Robert-Bosch-Krankenhaus, Abt.Hämatologie,Onkologie u.Palliativmedizin

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Stuttgart : Robert Bosch-Krankenhaus Abt. Hämatologie / Onkologie

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Traunstein : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Triberg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Trier : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Tubingen : Universitat Tubingen

TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia

Tübingen : Universitätsklinikum Tübingen

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Tübingen : Universitätsklinik für Kinder- und Jugendmedizin Tübingen

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Tübingen : 1015 - Universitätsklinikum Tübingen

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Tübingen : University Hospital

Dose-reduced Versus Standard Conditioning in MDS/sAML

Tübingen : University Hospital Tübingen

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Ulm : Universitätsklinikum Ulm

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Ulm : Investigational Site Number 276001 Updated

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Ulm : University Hospital Ulm Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Ulm : University Hospital Ulm

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

Ulm : 1270.1.49001 Boehringer Ingelheim Investigational Site

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Ulm : Universitätsklinikum Ulm

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Ulm : 1005 - Universitätsklinikum Ulm

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Ulm : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Ulm : 1230.4.49001 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Ulm : Novartis Investigative Site

Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)

Ulm : Universitätsklinikum Ulm, Klinik für Innere Medizin III, Comprehensive Cancer Center Ulm (CCCU)

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Ulm : University of Ulm

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Ulm : Universitätsklinikum Ulm

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Ulm : Medizinische Klinik und Poliklinik

TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia

Ulm : Novartis Investigative Site

To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib

Ulm : Universitätsklinik Ulm Klinik für Innere Medizin III Zentrum für Innere Medizin

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Velbert : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Viersen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Villingen-Schwenningen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Waiblingen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Weiden : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Weilheim : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Wendlingen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Wilhelmshaven : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Wuerzburg : GSK Investigational Site Updated

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Wurzburg : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Würzburg : Julius-Maximilians-Universität, Medizinische Klinik und Poliklinik II

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Würzburg : Universitätsklinikum Würzburg

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Würzburg : 1001 - Julius-Maximilians-Universität Würzburg

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Würzburg : Klinikum der Universität Würzburg

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Zella-Mehlis : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Athens : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Athens : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Athens, : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Athens, : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Herakleion : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

View More »

Ioannina : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Larisa : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Patras : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Thessaloniki : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Thessaloniki : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Thessaloniki : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Thessaloniki : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Hong Kong : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Budapest : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Budapest : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Budapest : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Debrecen : Debreceni Egyetem Orvos-es Egeszsegtudomanyi Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Debrecen : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

View More »

Debrecen : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Debrecen : Debreceni Egyetem Orvos - es Egeszsegtudomanyi Cent

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Debrecen : University of Debrecen Medical and Health Sciences Center

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Gyor : Petz Aladar Country Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Gyor : Petz Aladar Megyei Oktato Korhaz, II. Belgyogyaszati Osztaly Haematologia

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Gyor : Petz Aladar County Hospital

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Kaposvar : Kaposi Mor Oktato Korhaz Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Kaposvar : Kaposi Mor Oktato Korhaz

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Kaposvar : kaposi Mor Oktato Korhaz Belgyogyaszati Osztaly

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Kecskemét : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Pecs : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Szeged : Szegedi Tudomanyegyetem II Belgyogyaszati Klinika Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Szeged : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Szeged : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Szeged : Szegedi TudomanyegyetemII Belgyogyaszati Klinika

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Szeged : Szegedi Tudomanyegyetem, 11. Belgyogyaszati Klinika

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Tatabanya : Szent Borbala Korhaz

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Ahmedabad : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Ahmedabad : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Bangalore : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Bangalore : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Kolkatta : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

View More »

Madurai : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Mumbai : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Mumbai : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Mumbai : Local institution Updated

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Mumbai : Local institution Updated

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Mumbai : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Mumbai 400 020 : Novartis Investigative Site

Suboptimal Study Comparing Nilotinib and Imatinib

Navrangpura, Ahmedabad : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Pune : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Trivandrum : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Vellore : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Dublin : St James's Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Dublin : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Limerick : Midwestern Regional Hospital Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Afula : Haemek Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Afula : Haemek Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Ashkelon : Barzilai Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Beer Sheva : Soroka Medical Center

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Beer Yaakov : Assaf Harofeh Medical Centre

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

View More »

Beer-Sheva : Soroka Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Haifa : Updated

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

Haifa : Bnei Zion Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Haifa : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Haifa : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Jerusalem : Hadassah-Hebrew University Medical Center

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Jerusalem : Shaare Zedek Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Jerusalem : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Jerusalem : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Jerusalem : Shaare Zedek Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Jerusalem : Hadassah Medical Center

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Jerusalem : Shaare Zedek Medical Center

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Kfar Saba : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Kfar-Saba : Meir Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Kfar-Saba : Meir Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Nahariya : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Petach Tikva : Updated

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

Petach Tikva : Rabin Medical Center

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Petach-Tikva : Rabin Medical Center- Beilinson Campus Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Petach-Tikva : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Petah Tikva : Belinson Hospital

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Ramat Gan : GSK Investigational Site

Observational Study of Nelarabine in Children and Young Adults

Ramat Gan : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Ramat Gan : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Ramat Hadassah : Novartis Investigative Site

Safety and Efficacy of Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia Patients

Rehovot : Updated

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

Rehovot : Kaplan Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Rehovot : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Rehovot : Kaplan Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Rehovot : Kaplan Medical Center

The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

Tel Aviv : GSK Investigational Site

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Tel Aviv : Sourasky Medical Center

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Tel Hashomer : Sheba Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Tel Hashomer : Chaim Sheba Medical Center - Tel Hashomer, Heart Institute

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Tel-Aviv : Tel Aviv Sourasky Medical Center Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Tel-Aviv : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Tel-Aviv : Tel Aviv Sourasky Medical Center Hematology Clinic

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Tel-Hashomer : Sheba Medical Center

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Zrifin : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Alessandria : Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Alessandria : Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Ancona : Ospedali Riuniti Umberto I Lancisi Torrette di Ancona

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Ancona : Azienda Ospedaliera Universitaria - Ospedali Riuniti di Ancona

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Avellino : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

View More »

Bari : Azienda Ospedaliera Poloclinico di Bari Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Bari : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bari : Azienda Ospedaliera Policlinico di Bari

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Bari : Azienda Ospedaliera Policlinico di Bari

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Bergamo : Ospedali Riuniti di Bergamo

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Bergamo : 1301 - Ospedali Riuniti di Bergamo

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Bologna : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Bologna : Pfizer Investigational Site

A Trial In Patients With Advanced Cancer And Leukemia

Bologna : 1303 - Istituto di Ematologia "L.& A.Seràgnoli" Azienda

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Bologna : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Bologna : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Bologna : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Bologna : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Bologna : Azienda Ospedaliero-Universitaria di Bologa Policlinico S. Orsola-Malpighi

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Bologna : Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli" Università degli Studi di Bologna

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Bologna : Azienda Ospedaliera Sant'Orsola Malpighi

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Bologna : Istituto di Ematologia "L e A Seragnoli" Policlinico S.Orsola-Malpighi

Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia

Brescia : 1314 - Azienda Ospedaliera Spedali Civili Brescia

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Brescia : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Brescia : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Brindisi : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Brindisi : Ospedale "A. Perrino", U.O. Compessa di Ematologia

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Cagliari : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Catania : Azienda Ospedaliera Vittorio Emanuele-Ferrarotto Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Catania : 1313 - Universita di Catania

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Catania : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Catania : Azienda Ospedaliera-Universitairia Vittorio Emanuele-Ferrarotto-Santo Bambino

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Catanzaro : A.O. Pugliese Ciaccio Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Catanzaro : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Cosenza : Azienda Ospedaliera Annunziala Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Cuneo : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Ferrara : Azienda Ospedaliero-Universitaria Sant'Anna, Sezione di Ematologia, Dipartmento di Science Biomediche e Terapie Avanzate

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Firenze : Ospedale di Careggi

Dose-reduced Versus Standard Conditioning in MDS/sAML

Firenze : Ospedale di Careggi

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Firenze : Novartis Investigationl Sie

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Firenze : 1230.4.39005 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Firenze : Azienda Ospedaliera Universitaria Careggi di Firenze

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Firenze : Azienda Ospedaliera Universitaria Careggi

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Firenze : Azienda Ospedaliero-Universitaria Careggi

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Florence : Azienda Ospedaliera Universitaria Careggi Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Genoa : 1312 - Azienda Ospedaliera Universitaria San Martino

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Genova : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Genova : Azienda Ospedaliera San Martino Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Genova : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Genova : University Hospital San Martino

NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)

Genova : Azienda Ospedaliera Universitaria San Martino

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Genova : Clinica Ematologica- A.O.U. San Martino

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Genova : Dipartimento di Medicina Interna - Università di Genova

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Genova : Ospedaliera Universitaria San Martino di Genova

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Lecce : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Lecce : U.O. Ematologia "Vito Fazzi" Lecce

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Lecce : Ospedale "Vito Fazzi", U.O Ematologia

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Livorno : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Meldola : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Milan : IEO- Istituto Europeo di Oncologia Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Milan : Fondazione San Raffaele del Monte Tabor I.R.C.C.S Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Milan : Ospedale Maggiore Policlinico Mangiagalli e Regina Elena

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Milan : IEO- Istituto Europeo di Oncologia

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Milan : Fondazione San Raffaele

TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia

Milano : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Milano : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Milano : Ospedale Maggiore di Milano

Dose-reduced Versus Standard Conditioning in MDS/sAML

Milano : Ospedale Maggiore di Milano

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients

Milano : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Milano : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Milano : GSK Investigational Site Updated

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Milano : 1230.4.39001 Boehringer Ingelheim Investigational Site

Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia

Milano : Instito Europeo di Oncologia

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Milano : I.R.C.C.S Ospedale S. Raffaele

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Milano : Fondazione San Raffaele del Monte Tabor

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Modena : Azienda Ospedaliero Universitaria di Modena Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Modena : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Modena : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Modena : Azienda Ospedaliero-Universitaria Policlinico di Modena

TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia

Monza : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Monza : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Monza (Mb) : Local Institution

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Monza (Mi) : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Naples : Azienda Ospedaliera Universitaria Federico II Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Naples : Ospedale Cardarelli

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Napoli : 1309 - Azienda Ospedaliera Antonio Cardarelli

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Napoli : Novartis Investigatinal Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Napoli : Novartis Investigative Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Napoli : Divisione di Ematologia - Università degli Studi di Napoli "Federico II"

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Napoli : Dipartimento di Biochimica e Biotecnologie Mediche - Università degli Studi di Napoli "Federico II"

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Napoli : AORN "A. Cardarelli", U.O.S.C. Ematologia con TMO

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Nocera Inferiore : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Novara : Universita del Piemonte Orientale Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Novara : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Novara : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Novara : GSK Investigational Site Updated

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Novara : Azienda Osperdaliera Universitaria Maggiore della Carità

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Novara : Azienda Ospedaliero Universitaria Maggiore della Carità Di Novara

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Novara : Azienda Ospedaliero-Universitaria Maggiore Della Carita, Struttura Complessa Direzione Universitaria Ematologia

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Orbassano : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Orbassano : S.C. Medicina Interna II ed Ematologia - Laboratorio di Medicina Interna e Molecolare - A.O. San Luigi

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Orbassano : Azienda Sanitaria Ospedaliera "San Luigi Gonzaga"

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Orbassano (Torino) : AOU S.Luigi Gonzaga

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Orbassano(To) : Local Institution

Dasatinib Combo With SMO Inhibitor (BMS-833923)

Padova : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Padova : Università degli Studi di Padova Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Padova : Universita degli Studi di Padova

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Padova : Azienda Ospedaliero Universitaria di Padova

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Palermo : 1308 - Ospedali Riuniti "Villa Sofia-Cervello"

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Pavia : novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Pavia : Divisione di Ematologia - IRCCS Policlinico S. Matteo

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Pavia : Fondazione IRCCS, Policlinico S. Matteo - Dipartimento di Ematologia

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)

Perugia : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Perugia : Universita degli Studi di Peugla

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Pesaro : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Pescara : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Piacenza : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Pisa : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Pisa : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Pisa : Azienda Ospedaliero Universitaria Pisana - Università degli Studi di Pisa - Ospedale Santa Chiara

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Potenza : Azienda Ospedaliera Ospedale San Carlo Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Potenza : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Potenza : Ematologia Azienda Ospedaliera Ospedale San Carlo

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Ravenna : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Ravenna : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Ravenna : U.O. Ematologia - Dipartimento di Oncologia ed Ematologia, Presidio Ospedaliero di Ravenna

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Reggio Calabria : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Reggio Calabria : Azienda Ospedaliera Bianchi-Melacrino-Morelli

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Reggio Emilia : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Reggio Emilia : U.O. Ematologia - Arcispedale Santa Maria Nuova

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Rimini : Updated

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Rionero in Vulture : IRCCS Centro di Riferimento Oncologico di Basilicata di Rionero in Vulture

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Roma : Novartis Investigative Site

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Roma : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Roma : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Roma : Updated

CLL11: A Study of RO5072759 (GA101) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Roma : Novartis Investigative Site

Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)

Roma : Novartis Investigative Site Updated

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Roma : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Roma : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Roma : Cattedra di Ematologia - Università "Tor Vergata"

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Roma : Cattedra di Ematologia - Università "La Sapienza"

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Roma : Policlinico Universitario Agostino Gemelli

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Roma : Azienda Policlinico Umberto I di Roma

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Rome : Universita degli Studi di Roma La Sapienza Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Rome : Università La Sapienza di Roma

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Rome : 1302 - Università La Sapienza di Roma

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Rome : 1310 - Fondazione Policlinico Tor Vergata

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL

Ronciglione : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Rossano : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

San Giovanni Rotondo : Divisione di Ematologia - Casa Sollievo della Sofferenza

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Sassari : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Siena : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Siena : Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria alle Scotte

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Siena : U.O.C. Ematologia e Trapianti - Policlinico "Le Scotte"

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Siena : AOU Senese - Policlinico S. Maria alle Scotte

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Taranto : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Terni : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Torino : Local Institution

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Torino : Novartis Investigative Site

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia

Torino : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Torino : GSK Investigational Site Updated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

Torino : Azienda Ospedaliero Universitaria San Giovanni Battista di Torino

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Torrette di Ancona : Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Trento : U.O. Medicina II Divisione - Ospedale Santa Chiara

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Treviso : Novartis Investigational Site

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

Turin : AOU S Giovanni Battista Updated

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)

Udine : Clinica Ematologica - Policlinico Universitario

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Udine : Azienda Ospedaliero Universitaria S. Maria della Misericordia di Udine

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Varese : Ospedale di Circolo e Fondazione Macchi

Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

Verona : 1311 - Azienda Ospedaliera di Verona

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor ALL